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ABSTRACT

Heparin and heparan sulfate (Hp/HS) are linear complex glycosaminoglycans (GAGs),
which are involved in diverse biological processes. Although Hp/HS GAGs influence numerous
physiological and pathophysiological processes, their high degree of size polydispersity and
sequence microheterogeneity make structure-function characterization challenging. In addition, it
is hard to understand the structures that underlie any of the various functions with MS, because of
the lability of the sulfate group during tandem mass spectrometry (MS/MS) analysis. The work
presented here describes an in-depth approach for functional oligosaccharide characterization
including chemical derivatization of Hp to inhibit COVID-19 infection, multi-dimensional liquid
chromatography (LC) fractionation method, chemical derivatization coupled with LC-MS/MS
sequencing method, and MS-based fast photochemical oxidation of carbohydrates (FPOC) for
glycan-protein interaction study. Collectively, the work provides efficient strategies to recognize
the complex Hp/HS structure-function relationships, gaining more complete knowledge of
glycomics.
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CHAPTER I

INTRODUCTION
Proteoglycans (PGs)
Proteoglycans (PGs) are produced by almost all mammalian cells and presented into the
extracellular matrix (ECM), plasma membrane, or secretory granules. Proteoglycans have a core
protein with one or more covalently attached glycosaminoglycan (GAG) chains 1. Functionally,
PGs are involved in numerous cellular processes, such as growth, migration, differentiation,
survival, homeostasis, and morphogenesis 2.
Mammalian PGs are classified into four types: intracellular PGs, cell surface PGs,
pericellular-basement membrane PGs, and extracellular PGs, according to the location of those
proteoglycans, the homology of the protein sequencing, and the presence of unique protein
modules

3

(as represented in Figure 1.1). Extracellular PGs, the largest class, consist of two

subfamilies, hyalectans and small leucine-rich proteoglycans (SLRPs) 4. Hyalectans are hyaluronic
acid (HA) and lectin binding PGs, including aggrecan, versican, neurocan, and brevican 5.
Aggrecan is the major PG in cartilage to compensate compressive forces while versican is widely
expressed in various tissues regulating cell adhesion, migration, and inflammation 6. Neurocan and
brevican are predominantly expressed in the brain and implicated in nerve injury 7. SLRPs help to
stabilize collagen fiber and to modulate cell signaling pathways 8. Pericellular-basement membrane
1

PGs, including prelecan and agrin, are not only part of the basement membrane, but also interact
with other basement membrane components and cell-surface receptors 9. For cell surface PGs,
syndecans and glypicans are the main components, which can mediate the uptake of ligands in
cultured cells 10. Moreover, syndecans are highly involved in tissue-specific manner during normal
development as well as disease progression 11, 12. Serglycin is the only discovered intracellular PG,
which plays an important role in reserving biomolecules in granules 13, 14.

Serglycin
Hp/CS

FIGURE 1.1: CLASSIFICATION AND SCHEMATIC REPRESENTATION OF PROTEOGLYCANS .
A symbol nomenclature of the various glycosaminoglycans is described. CS, chondroitin sulfate; KS, keratan sulfate;
DS, dermatan sulfate; HS, heparan sulfate; Hp, heparin 15.
2

The diverse biological functions of PGs are mainly driven by the tremendous structural
variances in PGs 16. First, various PGs can have one or more GAG chains 17, 18. Some like decorin,
only have one GAG chain whereas others like aggrecan can have more than 100 chains 19, 20.
Second is due to the stoichiometry of GAG chain substitution 21. Take syndecans-1 as an example,
there are 5 sites which could be attached by GAGs 22. Moreover, the GAG at each site is not the
same 23. Thus, for a PG with defined core protein in different cell types, there are disparate
structures with different amounts of GAG chains and various structural modifications on GAG
chains 24.
To a large extent, it is the GAG chain that mainly contributes to the multiple biological
functions of PGs with limited proteins identified in PGs 25, 26. Over hundreds of GAG-binding
proteins have been discovered 27. For example, laminin binds with GAGs to promote cell adhesion
28.

Human Roundabout receptor (Robo1) binds with GAGs to involve in axon guidance 29. Viral

envelope proteins, such as herpes simplex virus, dengue virus, Zika virus, and hepatitis C virus
bind with GAGs to infect host cells 30, 31, 32. Nevertheless, the structure-function relationships of
GAGs with their binding proteins are poorly understood.
Glycosaminoglycans (GAGs)
Glycosaminoglycans (GAGs) are linear polysaccharides with a repeating disaccharide
motif, which consist of an amino sugar (glucosamine, GlcN) and a uronic acid (glucuronic acid,
GlcA or iduronic acid, IdoA) or galactose (Gal) 33. Based on the difference on the disaccharide
motif, GAGs are classified into four classes (Figure 1.2): hyaluronan (HA), keratin sulfate (KS),
chondroitin sulfate (CS)/dermatan sulfate (DS), and heparin (Hp)/heparan sulfate (HS) 34.
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FIGURE 1.2: DISACCHARIDE MOTIFS OF THE GAGS.

Typically GAG biosynthesis initiates by the attachment of a monosaccharide to an amino
acid, followed by polymerization and site-specific chain modification (epimerization,
deacetylation and/or sulfation) 35. Unlike RNA and proteins, this biosynthesis is untemplated and
modification is often incomplete. Indeed, the structures of GAGs depend on a complex interregulation of genetic code and environment 36. Each class of GAG has different biosynthesis
pathway, which results in unique structures and biological properties. The detailed biosynthesis
process for each GAG is discussed as follows.
HA is unique and the simplest polysaccharide in GAG family. HA has no sulfation on the
disaccharide repeat and no epimerization of the uronic acids (-4GlcA1-3GlcNAc1-)

37.

Moreover, it is the only GAG that is not covalently linked to a protein 38. It is normally synthesized
at the plasma membrane rather than the Golgi like other GAGs, because the enzymes to catalyze
HA synthesis, hyaluronan synthases (HASs), are located on the plasma membrane 39, 40. HASs use
4

cytosolic UDP-glucuronic acid and UDP-N-acetylglucosamine

as substrates

to add

monosaccharides to the reducing end of the polymer. The growing HA chain extrudes through the
membrane to form a large portion of the ECM

41.

The average molecular mass of HA is

approximately 1000-8000 kDa 42. HA can hold over 1000 times its weight in water to maintain
moisture within the cells of skins due to the negatively charged carboxyl groups on the glucuronic
acid (pKa 4-5) under normal physiological conditions 43, 44. HA is widely present in the skin, eye,
and almost all tissues and fluids of the body to provide resiliency. HA is also involved in diverse
biological functions, such as early development, tissue organization, cell proliferation,
inflammation, and tumor progression 45, 46, 47, 48, 49, 50.
KS is a linear poly-N-acetyllactosamine with a galactose (Gal) and N-acetylglucosamine
(GlcNAc) repeating disaccharide motif (-3Gal1-4GlcNAc1-)

51.

As a part of biosynthesis,

GlcNAc 6-O-sulfation can occur on the nonreducing end GlcNAc catalyzed by GlcNAc 6-Osulfotransferases, which is a prerequisite to chain elongation 52, 53. 6-O-sulfation can also occur on
the nonreducing end and internal Gal activated by Gal 6-O-sulfotransferase 54. KS can be found on
proteoglycans in cornea as KSI, in cartilage as KSII, and in brain as KSIII 55.
CS/DS is synthesized on the common tetrasaccharide (GlcA–Gal–Gal–Xyl–O-Ser),
identical to Hp/HS, as glycosaminoglycan (GAG) sidechains of corresponding proteoglycans (PGs)
and composed of variably sulfated disaccharide motif (-4GlcA/IdoA1-3GalNAc1-) 56. During
CS biosynthesis, the first GalNAc is added on the tetrasaccharide region by GalNAc transferase I
and the repetitive disaccharide unit is synthesized by GlcAT-II (GlcA transferase II) and
GalNAcT-II (GalNAc transferase II), respectively 57. O-sulfations can occur on the 4-/6- positions
of GalNAc and 2- position on GlcA on CS 58. DS is derived from CS via epimerization GlcA
5

residue to IdoA and sulfation at 2-O position 59. CS is the most abundant in ECM at 40-56% of the
total amount of GAGs 60. Variations in the relative amount of CS, types of CS and the ways of its
organization contribute to many diverse forms of ECM of various tissues including bone, skin,
blood vessel, brain and some others 61, 62, 63, 64, 65.
Hp/HS is the most complex and heterogenous member of the GAG family consisting of
the repeating disaccharide motif (-4GlcA/IdoA1-4GlcNAc1-) with diverse sulfation patterns 66.
As shown in Figure 1.3, the biosynthesis of HS initiates by attaching a GlcNAc to the common
tetrasaccharide and extends the chain by polymerase complex 67. The chain is further modified by
a series of enzymes including the N-deacetylase/N-sulfotransferase (NDST), C5 epimerase, 2-Osulfotransferase, 6-O-sulfotransferase and 3-O-sulfotransferase 68. Usually, the epimerization of
GlcA to IdoA is catalyzed by C5 epimerase, which recognizes the GlcA adjacent to GlcNS toward
the non-reducing end 69. The epimerization strongly influences the subsequent 2-O-sulfation on
IdoA/GlcA 70. The addition of 3-O-sulfate on GlcNS is relatively rare in nature and is commonly
regarded as the last modification in biosynthesis 71, 72, 73. As the modification is incomplete and not
coordinately regulated, the modification results in tremendous heterogeneity given 48 estimated
disaccharide blocks 74. The number of potential structures will exponentially increase as chain
length increases. Even though Hp and HS fall into the same category in GAG family, there is a
slight difference between Hp and HS. In general, Hp has more N-sulfation (> 80% GlcNS) and
uronic acid epimerization (> 70% IdoA) than HS 75. HS is widely found, almost expressed by all
cell types whereas Hp is mainly produced in the secretory granules of mast cells 76, 77.
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FIGURE 1.3: THE

STRUCTURE OF HEPARAN SULFATE

(HS)

PROTEOGLYCAN AND ENZYMES INVOLVED IN

BIOSYNTHESIS 78.

Significance and challenge for functional oligosaccharide study
During evolution, even though the core proteins are highly diverse, the biosynthesis of
proteoglycans is evolutionally conserved by the glycosaminoglycan chains 79. Hp is widely found
in the animal kingdom from invertebrate organisms to vertebrates, like in sand dollar, crab 80,
freshwater mussel 81, whale 82, mouse 83, human 33, 84. Similarly, HS is also reported in the nervous
system for invertebrates and vertebrates, such as in zebrafish 85, in mouse 86, and in C. elegans 87,
88.

The evolutional conservation of glycosaminoglycans indicates a fundamental role in biological

processes. Collectively, studies of functional GAG oligosaccharides are significant for us to
understand fundamental biological processes.
High sulfation of Hp/HS is one of the maintained characteristics throughout the evolution
89.

The study of marine invertebrates and vertebrates shows that GAGs in mollusks at a high salt

concentration are more sulfated than that in vertebrates 90. The high degree of sulfation helps the
lower organisms to accommodate the salinity in their habitat. In addition, sulfation amount and
7

sulfation pattern are highly involved in bacterial/viral infection 91. Highly sulfated GAGs on the
extracellular surface can electrostatically interact with viral glycoproteins or viral capsid proteins
so that viruses can be concentrated on the cell surface and bind with specific entry receptor 92.
Rather than a simple charge interaction, some viruses require certain sulfation patterns for
infection, like N-sulfation for respiratory syncytial virus infection 93. Further studies are highly
needed to elucidate the structural information of GAGs acquired/required in evolution.
It is extremely challenging to analyze structures of GAGs due to the structural
microheterogeneity and enormous diversity

94.

GAGs are usually fractionated to lower the

structural complexity by many high-performance liquid chromatography (HPLC) methods prior
to structural sequencing 95, 96. In most of cases, however, one-step separation is still not sufficient
to discriminate these complex oligosaccharides samples, especially isomers with various sulfation
patterns and epimers. The purity of separated glycan can also influence the subsequent highthroughput functional screening, like the size of glycan library for glycan microarray 97. The
orthogonal combination of HPLC methods have shown probabilities to resolve more structures
from a complex sample 98, 99. An orthogonal combination of HPLC methods with a high resolution
and cross-compatibility will advance the structural and functional studies of GAGs.
Nuclear magnetic resonance (NMR) and mass spectrometry (MS) have been demonstrated
as two powerful tools for structural characterization 100, 101. NMR provides valuable structural
information of GAGs, including glycosidic linkage, uronic acid types, and sulfation patterns,
which are useful for further computational modeling

102, 103.

But low sensitivity is a major

restriction in application of NMR, requiring a large amount of pure sample for complete structural
characterization 104. MS with high sensitivity is more preferred to sequence structures of GAGs in
8

low amounts, especially for biologically derived GAGs

105.

Furthermore, online HPLC-MS

analysis enables the structural study of mixture samples 106. A highly sensitive online HPLC-MS
based method is reported to completely resolve positional isomers of disaccharides from
depolymerized Hp/HS and measure the disaccharide compositions of Hp/HS from various cell
lines

107.

However, methods based on disaccharide composition fail to measure how those

disaccharides are organized into functional oligosaccharide units. Clearly, every method has
advantages and limitations on solving certain problems. The current challenge of MS based
characterization methods is to accurately and sensitively confirm the uronic acid type and the
sulfation patterns of GAG oligosaccharides 108, 109. Any MS method addressing the challenge will
provide accurate information of sulfation patterns and uronic acid type of GAGs.
Glycans are involved in diverse biological processes, most via carbohydrate-protein
interaction 110. The interaction has a relatively low binding affinity, which Kd value lies in the range
of M to mM 111. There are many approaches to study the interactions, such as titration calorimetry,
glycan microarray, and surface plasmon resonance 112, 113, 114. Each approach has disadvantages
limiting the broad application. Isothermal titration calorimetry is widely known as a golden
standard to measure the equilibrium binding constant 115. The low sensitivity, high sample demands
and low-throughput nature of the technique are major drawbacks 116. Pure and well-characterized
glycans are required by both glycan microarray and surface plasmon resonance 117. Thus, an indepth approach for functional oligosaccharide study including separation, sequencing and
characterization of the interaction will help resolve the essential glycans in biological processes.
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Structural analysis of GAGs
High-performance liquid chromatography (HPLC) methods
Many HPLC methods have been developed to purify complex GAGs for structurefunctional study. Each method has advantages and limitations for GAGs separation. Based on each
retention mechanism, the GAGs can be separated based on the difference in size, sulfation amount
or even sulfation pattern. But larger complex GAG oligosaccharides cannot be fully separated by
any of them alone. The orthogonal combination of various separation methods has shown promise
for GAGs’ purification. Ultraviolet (UV) detection is a very common method to analyze the
disaccharide composition of Hp/HS from cells for glycomics profiling 118. The chromophore is a
carbon-carbon double bond caused by Hp lyase digestion at the glycosidic linkage. The carboncarbon double bond can be detected by UV absorption at 232 nm wavelength 119. But the amount
of HS from biological samples may still not meet the detection limit of UV analysis. Several
fluorescent molecules have been introduced to enhance the sensitivity of UV analysis, such as 2aminoacridone, 2-aminobenzamide, and aminomethylcoumarin 120, 121, 122.Recently, a fluorophore,
BODIPY, has been demonstrated to significantly lower the detection limit to fmol for disaccharide
separation 123.
Size exclusion chromatography (SEC)
As GAGs partially depolymerized by enzymatic action commonly differ by a disaccharide
unit in length, SEC is usually the first step of isolation to prepare size fractions based on
disaccharide increments. The method was first developed in late 1950s and named as gel
permeation chromatography or gel filtration chromatography 124, 125. Preparative SEC is generally
10

performed on an in-house packed gel column, filled with porous spherical particles. SEC is a nonbinding separation method as the resin does not absorb or bind to the analyte. Analytes with smaller
hydrodynamic radii diffuse in the pores of the resin and elute from the column later, usually in an
isocratic gradient. Analytes with larger hydrodynamic radii will be able to enter fewer of the pores
in the resin, so it will elute earlier from the column. The mobile phase usually consists of
ammonium salts, making SEC highly compatible with other separations 126. However, preparative
SEC has low sensitivity, low resolution due to low pressure, and is often time-consuming (> 1 day)
127.

The high-pressure SEC column has been developed to improve sensitivity of HPLC separation

of Hp/HS 128. The depolymerization profile of low molecular weight e can be determined by SEC
LC-MS analysis 129. However, oligosaccharide modifications cannot generally be fully resolved
by SEC due to the low resolution.
Strong anion exchange chromatography (SAX)
GAGs are highly negatively charged molecules in the living system 130. Undoubtedly, SAX
is the most common separation method of GAGs and is also the quality control method of
pharmaceutical Hp recommended by FDA 96, 131. This chromatography mode was first developed
in the mid 1970s 132. It is widely used in the separation not only of complex GAGs, but also of
charged biomolecules such as peptides, proteins, nucleic acids, and biopolymers 133, 134, 135, 136.
The anion-exchange chromatography is selected for negatively charged analyte, usually
filled with positively charged diethyl amino ethyl or quaternary ammonium resin 137, 138. Once
loaded on the column, the negatively charged analyte electrostatically interacts with the counterion
resin. Then analyte can be displaced from the resin by increasing the concentration of competitive
11

ions (commonly sodium chloride at pH 3.5) in the mobile phase 139. GAGs with fewer sulfo groups
have less interaction with the resin and will be eluted earlier from SAX. Whereas, more sulfated
GAGs have more interaction with resin and will be eluted later from SAX. With this elution order,
SAX has broad applications in assessing the structural composition of GAGs from disaccharide
profiling to separation of oligosaccharide 140, 141. SAX solid phase extraction devices can also
separate and quantify Hp and HS from cells on a micro-scale 142. But SAX alone does not have
sufficient resolution to separate sulfation isomers of oligosaccharide, like hexasaccharides 143. The
combination of SAX with other separation methods is necessary. The combination is highly
limited due to the high concentration of sodium chloride used in conventional SAX, around 1 M
to 2 M. Only a separation method starting with water would be compatible with SAX. The
combination of SAX with porous graphitized carbon has been demonstrated to separate some HS
tetrasaccharide isomers, but the reproducibility of porous graphitized carbon chromatography may
still be an issue for highly sulfated larger GAGs 144. Volatile salt can be used in derivatized SAX
resin (cetrytrimethylammonium- C18 resin) to separate isomeric Hp hexsaccharides, which
improves resolution and allows combination with other separation methods starting with a high
organic gradient 145. The fractions from SAX can then be desalted prior to MS analysis, limiting
its application to trace samples due to sample losses during desalting process 146. SAX is still a
very powerful separation method for Hp/HS fractionation due to the high resolution 147.
Ion-pair reversed phase chromatography (IPRP)
Reversed-phase (RP) chromatography has been the most popular HPLC stationary phase
for various analyses 148. In RP, Octadecylated silica (C18) is the widely used stationary phase 149.
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The retention in RP is mainly governed by hydrophobic interaction of analyte between the elution
buffer and the stationary phase 150. However, anionic GAGs cannot be retained on nonpolar C18
resin. IPRP has been developed for anionic GAGs analysis 151.
The ion-pairing agents for GAGs consist of a large hydrophobic cation and a small
hydrophilic anion, added both to the aqueous and organic mobile phase 152. GAGs can then be
retained on RP via electrostatic interaction with ion-pair agents. Even through the mechanism of
retention is still unclear, there are two possible mechanisms involved 153. One is the partition
mechanism while the other is adsorption mechanism 154. In partition model, the ion pair agent in
the mobile phase first interacts with the anionic GAGs upon injection and forms the pseudo nonpolar complex. The pseudo non-polar complex can then retain in the nonpolar stationary phase and
follow the elution pattern as RP 155. In the adsorption model, the hydrophobic ion pair agent,
pentylamine, in the mobile phase is first absorbed into the nonpolar stationary phase and then
protonated by the counterion pair agent, acetic acid. The ion pair agents will form a transient ionexchange layer on the surface of RP. The anionic GAGs can be retained on RP via the electrostatic
interaction 156. The complicated retention mechanism of IPRP provides a high resolution for GAGs
separation, having various sulfate amount and sulfation patterns 157. Commercial disaccharides of
Hp/HS including isomers can be well separated by IPRP 158.
The common ion pair agents for GAGs analysis are acid and alkyl amine, such as tri-nbutylamine, pentylamine, hexylamine, tetrabutylamine, and tetrapropylamine. Acid is used to
protonate the alkyl amine and enables the interaction between the positive charged ammonium ion
and negative charged sulfate ion. Weak volatile acid such as formic acid or acetic acid is
13

traditionally used to protonate the alkyl amine 159. However, acetic acid could suppress ionization
in oligonucleotides analysis with triethylammonium acetate buffers 160. 1,1,1,3,3,3-hexafluoro-2propanol (HFIP) is reported to overcome the ion suppression issue caused by acetic acid for
negatively charged oligonucleotides 161. Similarly, for negatively charged sulfated GAGs, HFIP
could also elevate their MS signals by 10 to 100-fold varied on the chain lengths 162. The type of
alkyl amine, especially chain length, is the key factor on separation. The long alkyl amine has an
increased hydrophobicity which will absorb tighter with the non-polar reverse phase stationary
phase than short alkyl amine. The use of a long alkyl amine, like octylamine, will increase the
retention and thus improve the resolution. The drawbacks of octylamine are the wider peak shape
and the higher boiling point (176 C) than pentylamine. Thus, ion pair agents need to be selected
for certain HPLC separation and MS analysis.
Additionally, the concentration of ion-pair agents is another factor during method
development. In the study including 5, 15, 25, and 40 mM pentylamine, the peak capacity and
retention are increased with the increasing concentration until 15 mM and 25 mM, respectively 162.
The beneficial impacts are mitigated when the pH is close to the pKa of amine and attributed to
incomplete protonation

163.

Ten mM tetrabutyl amine provides best separation for Hp

oligosaccharide in range of dp2 to dp 14 while the best concentration of tributyl amine is 5 mM
for HS disaccharides separation 164, 165. MS signal is also poor with high concentration of short
amines, di- or trialkyl amines, and acetic acid in the elution buffer 166. Mainly because the large
amount of acetic acid is required to protonate high concentration of short amines. With a constant
electrospray ionization efficiency, more acetic acid consumes more current, leaving less portion
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to ionize the analyte and suppressing the signal. MS signal is not significantly influenced with high
concentration of pentylamine and HFIP. Overall, the concentration effect of amine on MS
detection is varied on the acid type, but the concentration of acid does not have a major effect on
separation performance regardless of acid type. But the concentration of acid does suppress MS
detection. For HFIP, MS response will also be lowered with 50 or 100 mM. During the method
development, there is a compromise between the chromatographic separation and MS detection.
In general, IPRP does not only have a high resolution, but is also a MS compatible chromatography.
Hydrophilic interaction chromatography (HILIC)
HILIC is a variant of normal phase liquid chromatography for separating polar compounds,
in which the stationary phase is more polar than the mobile phase 167. The acronym, HILIC, was
first proposed by Alpert in 1990 to describe the chromatography having hydrophilic stationary
phase and hydrophobic mobile phase 168. The HILIC stationary phase is typically modified silica
with polar functional groups. In 1975, amino-silica HILIC column, Bondapak, was first applied to
separate carbohydrates by Linden 169. HILIC column with DIOL-silica stationary phase was then
developed and widely used for protein separation

170.

Later, the Yoshida group has applied

nonionic carbamoyl bonded silica gel column, known as amide HILIC, for peptide separation 171.
Additionally, other chemically derivatized silica can be packed as the stationary phase, such as
aminopropyl bonded silica, cholesterol immobilized silica, n-acylamide, and silanols 172

173, 174.

As

various specific functional groups can be used as packing materials, different types of HILIC have
distinct retention mechanisms. Penta-HILIC not only provides better separation of glycopeptides
based on the glycan moiety than zwitterionic HILIC, but also has a highest chromatographic
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resolution for isomeric glycopeptides with different glycosylation comparing with bridged
ethylene hybrid amide HILIC and zwitterionic HILIC 175. For negatively charged GAGs, the less
basic and reactive amide HILIC column is more preferred than amine HILIC. Choosing the proper
HILIC column is the first step of method development.
The common mobile phase consists of organic solvent, usually acetonitrile, water and ionic
additives. Acetonitrile is widely used due to its low viscosity

176.

Besides that, the principle

retention mechanism of HILIC is via hydrogen bonds 177. As an aprotic solvent, the change of
acetonitrile gradient does not interfere with the retention behavior of analyte. Thus, acetonitrile is
favored in HILIC. Ionic additives in HILIC adjust the pH and ionic strength in the mobile phase,
which will affect the polarity of the analyte and thus influence its retention. For example, acetate
buffer was used to separate CS dp2-dp22 based largely on size with baseline separation

178.

Ammonium formate is reported to modify the separation of O-glycans, N-glycan 179s, and GAG
oligosaccharides based on the size 180, 181, 182. Methods with ammonium formate, being able to
separate Hp isomers, have a much higher resolution than those using acetate buffer 183. As the type
of ionic additive is highly correlated with the chromatographic resolution, choosing the right one
is important. The pH of the mobile phase also influences the retention of the analyte. For ionic
analyte separation, the pH determines the charge state of the analytes and in turn affects the
electrostatic interaction between the analytes and ionized residual silanol groups on the stationary
phase 184. For example, the pH of mobile phase in trifluoroacetic acid (TFA) is much lower than
that in ammonium formate, ionizing fewer silanol groups on the stationary phase. Thus, there is
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less ionic repulsion between the ionic analyte and the stationary phase in TFA solution, enhancing
retention and selectivity 185.
Even though there is no thorough theoretical explanation on separation mechanism,
partition is widely proposed as the main mechanism of HILIC 179. In this mode, the analytes retain
differently between the organic-rich mobile phase and the water layer enriched on the stationary
phase 186. The more hydrophilic analyte will partition more to the water layer on the stationary
phase, and thus elute later from the column. Analytes can be separated based on their polarities
and the degree of solvation in two solvents. There are other interactions highly involved in HILIC
separation as well, such as hydrogen bonds, and electrostatic interactions

187.

Overall these

mechanisms work together and provide useful separation for GAG family.
Porous graphitized carbon chromatography (PGC)
As the shielding effect of silanol on the surface of silica-based stationary phase is
detrimental to separation, non-silica-based stationary phases were highly demanded in 1970s 188.
Carbon-based stationary phases drew attention. Colin and Guiochon first developed silica particles
coated with pyrocarbon in 1976 189, but these particles had a poor chromatographic performance
even with a good mechanical resistance. Then porous glassy carbon was patented by Knox and
Gilbert in 1979 and published in 1982 190. This material was made of a porous template filled with
carbonizable resin, which enhanced separation but required additives to preserve symmetric peaks.
Later in 1986 porous graphitic carbon was introduced by Knox with both good mechanical
properties and chromatographic separation 191.
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There are several forms of PGC columns available on the market. One is now
commercialized by Thermo Scientific under the trade name of Hypercarb. The stationary phase
used silica gel as a template, along with a homogeneous mixture of phenol and hexamine. The
porous graphitic carbon was produced after series of reactions, such as polymerization,
pyrolyzation, immobilization, and graphitization

192, 193.

The second one was mixed the equal

quantities of carbon black with phenolic resin to initiate polymerization and patented under the
name of TSK-GEL Carbon-500 in 1993 194. The third was brought into the filed by Obayashi in
1994 under the trade name of BTR Carbon 195. This started with a low molecular weight tar and
polymerizable monomer. Even though PGC columns from different vendors have distinct physical
properties, they all provide similar chromatographic behavior 196.
The main retention mechanisms are composed of dispersive interactions and polar retention
effects on graphite 197. The dispersive interaction depends on the planarity of the stationary surface,
the polarizability of the analyte and the stationary phase, and their distance 198. Besides dispersive
interactions, Kaliszan was the first to notice that the retention was related to the localized polarity
of the analyte 199. By comparing the separation on PGC and that on RP, both Möckel and Tanaka
observed that the retention of PGC was longer than that on RP, suggesting the polarity effect of
the analytes on retention 200, 201. The term, polar retention effect on graphite, was carried out by
Ross to describe the relationship between the electronic density of analytes and the retention 202.
When the polar analytes approached to the surface of the stationary phase, it would induce the
polarization of the surface and then interact with the surface via dipole-dipole interactions.
According to this theory, the charge distribution in the analyte and the distance between the
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charged functional groups of analytes and the polarized surface would both interfere with the
retention. Therefore, PGC would separate isomers with various three-dimensional structures,
which would resolve sulfation isomers in GAGs study. Electronic repartition was another
suggested retention mechanism by Hanai 203. The electron distribution of the surface formed a large
polynuclear aromatic hydrocarbons, giving an electronic excess on the edges and an electronic
deficient in the center. The retention of polar analytes, like carbohydrates, was via hydrogen bonds
with the edges 204.
PGC has been widely applied to the separation of carbohydrates for decades. In 1991, 11
common disaccharides were separated on PGC and positional isomers could be well resolved on
PGC as well 205. In 2004, neutral O-glycans from the salivary mucin were separated on PGC
column and further sequenced by MS and MS/MS 206. Similar applications of PGC have been
reported for mapping N-glycans in various glycoproteins 207. The separations of CS, hyaluronan,
KS, Hp and HS were also reported on PGC

208, 209.

Moreover, sulfation isomers of HS

hexasaccharides could be separated and sequenced by PGC LC-MS 144. The advantage of coupling
PGC with MS for carbohydrates analysis is that the high ratio of organic gradient to elute the
carbohydrates promotes their ionization efficacy in ESI

210.

Even though PGC is a powerful

analytical method, the column regeneration and reproducibility are the main issues for highly
sulfated GAG oligosaccharides structural elucidation.
In Chapter 3, a three-dimensional separation scheme is first described, starting from SEC,
IPRP and ending with Amide-HILIC. The high resolving power is demonstrated by the complete
separation of three synthetic Hp hexasaccharides as well as low molecular weight Hp from natural
19

sources. This method also produces fractions after the three-dimensional separation that are
directly compatible with high throughput functional screening by microarray and/or direct
structural analysis by electrospray mass spectrometry. For the first time, the orthogonal separation
of underivatized Hp octosaccharides is successfully achieved.
Mass spectrometry (MS) methods
Mass spectrometry (MS) has been an essential tool in glycomics study. Several ionization
methods coupled with various MS analyzers have been applied to reveal the structural
compositions of glycans. Fast-atom bombardment (FAB) MS commonly ionizes molecules by
striking a beam of high energy atoms on the surface and is the first technique to structurally
characterize sulfated GAGs 211, 212. Based on FAB-CID tandem MS spectra, Dr. Domon and Dr.
Costello proposed the nomenclature for carbohydrate fragmentations and the Domon-Costello
nomenclature has been widely accepted in the field of carbohydrate research 213. However, the
extensive sulfate loss in FAB limits its application on Hp/HS with more sulfate groups per
disaccharide unit

214.

Matrix-assisted laser desorption/ionization (MALDI), a relatively soft

ionization compared to FAB, create ions by mixing analytes with laser absorbent matrix onto a
metal plate and followed by a pulsed laser beam

215.

The pioneer work of Koichi Tanaka

demonstrates a broad application of MALDI to biological macromolecules and has been honored
with a share of the 2002 Noble prize for chemistry 216, 217. However, the application of MALDI to
sulfated GAGs is mainly limited by the size of the oligosaccharide and the amount of sulfate group.
Hp oligosaccharides larger than DP10 with more than 13 sulfate groups cannot be ionized
efficiently by MALDI

218.

Similar to MALDI, electrospray ionization (ESI) is another soft
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ionization by applying a high potential to analyte droplets, causing solvent evaporation during
potential traversing and subsequent Coulombic explosion to generate ionized analyte 219. As liquid
can be ionized by ESI, ESI has a whole application with liquid chromatography methods for
structural characterization. In addition, ESI could produce multiply charged analytes, which is
beneficial to observe the mass of macromolecules in a small mass-to-charge (m/z) range and
observe more fragment ions during tandem MS analysis 220. Thus, ESI is one of the most popular
ionization techniques for carbohydrate sequencing.
To characterize detailed structural information, especially sulfation patterns, several
tandem MS fragmentation techniques have been developed. One of them is collisional induced
dissociation (CID). In CID, precursor ions collide with the collision gas and the bond with the least
vibrational energy will be cleaved and generate fragment ions and neutral products

221.

Higher

energy CID, HCD, is an alternative option of CID to produce more informative fragment ions,
especially cross-ring cleavages 222. CID can be employed to differentiate the epimerization of
CS/DS based on the profile of fragment ions 223, and to distinguish carbohydrate isomers when
coupled with ion mobility MS

224.

But the labile sulfate groups on Hp/HS will result in the

extensive sulfate loss during both CID or HCD, which is the major hurdle for Hp/HS sequencing.
Even though the sulfate loss can be minimized via hydrogen ion and metal cation exchange, online
HPLC-CID MS/MS analysis is still limited due to solvent compatibility 225.
As a sulfate group is labile and the sulfation pattern is the essential structural information
of sulfated GAGs, the low or no energy-based fragmentation techniques causing less sulfate loss
are highly on demand. Electron based activation methods, electron detachment dissociation (EDD)
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and negative electron transfer dissociation (NETD), are greatly advantageous to provide
informative ions including glycosidic bond and cross-ring fragments 226. EDD fragments ions by
combining the negative ions with electrons of moderate energy (15 to 20 eV) and generating
fragments after electron detachment

227, 228.

The first application of EDD to glycans was

demonstrated by GAG tetrasaccharides in 2007 229. Unique fragment ions are generated by EDD
of HS tetrasaccharide epimers by simple -cleavage to differentiate GlcA and IdoA 230. NETD is
the negative form of ETD. In NETD, electron transfers from the anion to the cation in the gas 231.
NETD generates similar fragment profile as EDD with less time required, which is more preferred
for high-throughput analysis, such as HPLC 232.
Photodissociation technique is another approach to characterize GAGs with minor sulfate
loss. Ultraviolet photodissociation (UVPD) fragments ions by exposing a pulsed laser with a high
flux of photons to ions 233. The electronic state of the ions after UV photoadsorption are activated,
and activated ions go through high-energy dissociation pathway 234. UVPD fragments Hp strange
spacing here disaccharides at 240 nm via the glycosidic bond and also produces series of A and X
types of cross-ring cleavages to resolve the sulfation pattern shown in Figure 1.4 235.
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FIGURE 1.4 UVPD ( = 240 NM) TANDEM MASS SPECTRUM OF UA-GLCN6S [M-H]-.

In addition, UVPD generates fragments from both glycosidic bond and cross-ring
cleavages retaining sulfation pattern for characterization of highly sulfated pentasaccharide,
Arixtra

236.

UVPD produces more fragments than CID and may characterize isomeric

oligosaccharides coupled with ion-mobility spectrometry 237. UVPD is a promising technique for
O-linked and N-linked glycopeptide sequencing 238, 239, 240. More research in UVPD of complex
sulfated GAGs is still required.
Ions are analyzed based on their mass to charge ratios (m/z) by the mass analyzer. The
commonly used mass analyzers in GAG sequencing are quadrupoles, orbitrap, time-of-flight
(TOF), and Fourier-transform ion cyclotron resonance (FT-ICR). Mass analyzers differ by their
resolving power, which highly impacts the capability of resolving the isotopic clusters and the
structures of complex GAGs oligosaccharides. Quadrupoles are able to analyze the disaccharide
compositions of HS/CS 241, but they fail to resolve the structures of longer CS oligosaccharides
differing by 0.051 Da, which requires 1:20000 resolving power for tetramers and 1:116000 for 24mers 106. Time-of-flight (TOF), with a moderate resolving power, is reported to characterize non23

sulfated HS oligosaccharides up to 40-mers when coupled with IPRP

242, 243.

Due to its low

detection sensitivity, TOF is not sufficient to detect the tandem MS spectra of low abundance
structures and further confirm the sequences 244. Fourier-transform ion cyclotron resonance (FTICR) is a significantly different mass analyzer, which detects ions passing near detection plates
rather than ions hitting a detector as TOF 245, 246, 247. Even though FT-ICR provides an unparalleled
resolution and accuracy, the high cost of high-field magnets and the slow scan rate limits its broad
application 248, 249. Orbitrap, a new member of Fourier transform MS family, was first presented at
the ASMS conference in 1999 250. Orbitrap has the advantages of both TOF and FT-ICR. For
example, orbitrap analyzes ions based on ion motion in electrostatic fields, similar to TOF
instrument 251. Both orbitrap and FT-ICR detect ions by nondestructive image current detection
and provide more accurate measurement 252. Orbitrap has become a powerful mass analyzer in a
wide range of application, such as in proteomics, in metabolomics, and in glycomics 253, 254, 255.
Chemical derivatization of GAGs
Chemical derivatizations play a vital role in GAGs analysis including alternating the
chromatographic properties, enabling high throughput functional screening, improving ionization
and fragmentation in LC-MS/MS analysis 256. To replace the labile sulfate groups and also to
distinguish the new hydroxyl groups formed after desulfation from the initial hydroxyl groups,
sequential chemical derivatization has been designed. Sequential chemical derivatization was
reported in 1993 to sequence Hp oligosaccharides by FAB MS

257.

Reductive amination,

permethylation, desulfation and acylation are common chemical derivatizations for GAG analysis.

24

Reductive amination affords many benefits for GAG analysis, as it facilitates the
fluorescent detection by coupling a fluorescent tag at the reducing ends of GAG and enables the
high throughput functional screening via glycan microarray analysis or surface plasmon resonance
258, 259.

Often natural glycans are first reduced by sodium borohydride or sodium cyanoborohydride

260, 261.

The semialdehyde group of the reducing end then reacts with a label containing a primary

amine group in dimethyl sulfoxide with acetic acid, resulting in an imine or Schiff base 262. There
are various labels or labeling kits available for glycans. Among them, 2-aminobenzamide (2-AB)
is the most widely used label and a standardized elution profile of 2-AB labeled milk
oligosaccharides in HILIC has been published for structural assignment

263.

2-amino-N-(2-

aminoethyl)-benzamide (AEAB) is a bi-functional fluorescent tag for glycan analysis. AEAB
contains two primary amines, one used for reducing end labeling, the other used for immobilization.
As a result, AEAB cannot only improve chromatographic detection, but also covalently
immobilize glycans to the NHS-activated or epoxide-activated surfaces for functional screening
264.

One hundred and thirty-four distinct glycomers of AEAB labeled N-glycans from

Caenorhabditis elegans have been printed on the shotgun array which allows the study of binding
requirement for the interested protein-carbohydrate interactions 265.
Permethylation is one of the most widely used derivatization method in MS analysis of
glycans. Permethylation addresses the stability issue of N-acetylneuraminic acid in N- and Oglycans and improves ionization efficiency 266. A rapid permethylation of glycans is first published
by Ishimoda and Hakomori in 1964 267, in which hydroxyl groups of glycans are first reacted with
the carbanion generated from methyl sulphoxide and sodium hydride and then replaced by methyl
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iodide. Ciucanu and Kerek improved the reaction yield from 30% to 98% in 1984 using solid
alkali-metal hydroxide as an effective base agent 268. With this reaction, the major concern is the
solubility of large sulfated GAGs in dimethyl sulfoxide (DMSO) solvent. To overcome this issue,
the GAGs sodium salts have been converted to their triethylammonium salts to improve the
solubility by Christian Heiss and co-workers 269. For non-sulfated neutral glycans, a rapid and
efficient solid-phase permethylation has been developed, allowing the derivatization performed in
the picomole scale within a minute 270.
During the permethylation, all the labile hydrogens are replaced by methyl groups,
including that on hydroxyl groups, on carboxyl group and on the amine group of glucosamine
while sulfate groups are free from the reaction. The amount of sodium hydroxide is critical to
achieve a high derivatization yield and avoid the peeling reactions and oxidative degradation
caused by -elimination

271, 272.

The solid-phase permethylation method, packing sodium

hydroxide beads into a spin column, has been developed to minimize the amount of sodium
hydroxide for neutral and sialylated glycans 273. The other approach is to reduce the uronic acid
into hexose prior to permethylation, avoiding the base catalyzed -elimination 274.
Permethylation can improve ionization efficacy and generate informative fragments
resulting from the glycosidic bond cleavages between glycans and cross-ring cleavages within the
glycan ring. After permethylation, the hydrogens are replaced by methyl groups, decreasing the
extent of intermolecular hydrogen bonding and avoiding dehydration 275. Thus, glycans will be
more stable in the gas phase. The hydrophobicity of glycans will be largely increased after
permethylation, resulting in more distribution on the surface of liquid droplet 276. As most ions are
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ionized from the surface of droplet, the surface molecules can retain the charge well during
evaporation and permethylation can thus improve the sensitivity 277. Moreover, interpretation of
fragment ions after permethylation is less ambiguous with significant and abundant signals for Nglycans characterization 278. The fragments generated after permethylation also help to distinguish
the sulfated N- and O- glycans from phosphorylated glycans 279.
Desulfation is a useful derivatization method to study the structure-function relationship
between sulfated GAGs and interesting proteins as sulfation patterns govern the molecular
recognition and activity 280. Due to various sulfation patterns of GAGs, desulfation consists of full
desulfation and site-specific desulfation. There are several methods for desulfation, including acidcatalyzed desulfation, alkali-catalyzed desulfation, solvolytic desulfation and sialylation reagent
involved desulfation 281, 282, 283, 284.
Acid-catalyzed desulfation was developed in 1950 while the permethylation method was
generally not applicable to sulfated polysaccharides at that time 285. The idea of acid-catalyzed
desulfation is from the cellulose acetate manufacture. In the manufacturing process, the
intermediates, sulfonic acid esters, are formed with the use of absolute sulfuric acid or hydrogen
sulfate and later replaced by acetate groups 286. Following Kuhn’s theory, the reaction probably
involves the simultaneous desulfation and acetylation of reducing glycan sulfates 287. In 1950,
Wolfrom and Montgomery reported a similar desulfation method for sulfated polysaccharide with
absolute sulfuric acid at low temperature 288. Later, the potassium chondroitin sulfate was fully
desulfated with dilute hydrogen chloride in methanol at room temperature 285. Hp was desulfated
with 0.06 M anhydrous methanolic hydrochloric acid 289. In 1963, Rees reported a water-based
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acid hydrolysis method, which desulfated carbohydrate sulfates in 0.25 M hydrochloric acid under
a boiling water bath 290. Acid hydrolysis favors N-sulfates over O-sulfates, as N-sulfates are more
acid-labile, limiting its application to the full desulfation of multiple sulfates 291. Even though acid
hydrolysis has selective, there is still O-desulfated side products in selective N-desulfation 292.
Moreover, depolymerization is inevitable for sulfated polysaccharides even with a mild acid
hydrolysis

293.

Acid hydrolysis shows promising to produce partially 2-O-desulfated Hp

derivatives under pH 1 at 60 C with 2D NMR analysis 294.
The fundamental understanding of the alkali-catalyzed desulfation was first done by E.G.V.
Percival 295. In his study, the C-1 was protected from the reaction, suggesting that the reaction was
based on a base-catalyzed elimination rather than hydrolysis. Through the treatment of sodium
hydroxide, 2-O sulfated uronic acid is desulfated to a 2,3-anhydro derivative after an
intramolecular attack of O-3 on C2 while 3,6-anhydrohexoside is formed during 6-O-desulfation
296.

However, if the C3 or C5 does not have a free hydroxyl group, 6-O-sulfated hexose will be

relatively stable to alkali 297. Hp containing 2,3 or 2,3,6 sulfated on GlcN can be 3-O-desulfated in
the alkaline solution after lyophilization by formation of the N-sulfo-aziridine ring 298. The main
drawback of alkali-catalyzed desulfation is the alkaline caused degradation starting at the reducing
end and resulted in an anhydrous chain 299.
Solvolytic desulfation is the most frequently used desulfation method of GAGs. The
solvolytic desulfation with methanolic hydrogen chloride was first applied to sulfated galactans,
resulting in unsatisfied depolymerization especially for ones having 3,6-anhydrogalactose residues
300

. Solvolytic desulfation in dioxane was once reported as a mild and rapid method of the
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pyridinium salts of sulfated steroid 301, 302. The reaction was optimized by Usov in 1971, converting
the sulfated carbohydrates to their pyridinium salts and performing the reaction in solvents as
pyridine, N,N-dimethylformamide, p-dioxane, and dimethyl sulfoxide 303. A similar reaction was
carried out with 4,6-sulfated CS in dimethyl sulfoxide containing 10% water or methanol at 80C,
resulting in 83% - 96% yields

304.

Unlike other desulfation methods, there is no significant

depolymerization under the solvolytic conditions based on the gel-filtration pattern 305.
Inoue and Nagasawa have done a thorough study of factors impacting the solvolytic
desulfation, such as the adduct salt and solvent 306. They found that pyridinium 2-deoxy-2-sulfoamino-D-glucose had the fast desulfation rate compared to that of ammonium or triethylammonium
salts. Then the decomposition rate of pyridinium salts descends in the order: pyridine > N, Ndimethylformamide > dimethyl sulfoxide > hexamethyltriamide phosphate > acetonitrile. Even
though the deposition rate in pyridine and N, N-dimethylformamide were much higher than that in
others, depolymerization happened after 7 h. Dimethyl sulfoxide was the best solvent in their study
with a rapid desulfation rate and little depolymerization. The rate of desulfation at 100C was
slightly improved with the increasing amount of water or methanol in the solution from 1% to 10%
283.

As the rate slowed down with 20% water or methanol, 10% of water or methanol was the best

amount for a rapid solvolytic desulfation following the proposed mechanism shown in Figure 1.5.

R OSO3/NHSO3 N

+

Me2SO

MeOH/H2O
R OH/NH2 +

+
N

H

FIGURE 1.5: PROPOSED MECHANISM OF SOLVOLYTIC DESULFATION.
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SO3-Solvent

Dr. Stortz’s group significantly shortened the reaction time from 6 hour to 1 min with microwaveassisted solvolytic desulfation 307. Although depolymerization did occur, this method suggests a
new approach to optimize the reaction.
Selective N-desulfation is likely achieved with mild conditions, at a lower temperature and
less exposure time. A solvolytic N-desulfation of Hp has been reported by treating the pyridinium
salt with dimethyl sulfoxide having 5% water or methanol for 1.5 h under 50C 308. Based on the
experimental result, the selective desulfation follows two-step reactions, shown in Figure 1.6 291.
The polar pyridine first converted the N-sulfated derivative to its dipolar type, followed by the NS bond cleavage and the formation of the amine. The reaction was quenched by adding excess
amount of water.
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FIGURE 1.6: PROPOSED MECHANISM OF SELECTIVE N-DESULFATION.

There is another desulfation approach with sialylation reagents. N, O-bis(trimethylsilyl)acetamide (BTAS) and N, O-bis(trimethylsilyl)trifluoro-acetamide were effective to selectively
remove the sulfated primary alcohols (6-O-sulfation) while methyl galactoside 2-, 3-, and 4sulfates were remained 309. The plausible explanation of selectivity might be the steric hindrance
to form a silyl ether linkage via secondary alcohol. Specific 6-O-desulfation without
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depolymerization were also obtained with CS and sulfated galactan assisted with BTAS at 60C
for 2 h 284. However, for highly sulfated Hp, incomplete removal of 6-O-sulfation was noticed
under the treatment of BTAS 310. Later the specific 6-O-desulfation of pyridinium Hp was achieved
using N-methyltrimethylsilyl-trifluoro-acetamide in pyridine for 2h 311. Although the mechanism
for this reaction is still unclear, sialylation reagents are widely applied to specific 6-O-desulfation
reaction.
Acylation is another essential chemical derivatization approach to reveal the structural
information of functional oligosaccharides. Generally, acylation is considered as an alternative
approach of permethylation which only reacts with hydroxyl groups and/or amine groups rather
than all hydrogens, especially those on carboxylic acid causing depolymerization during carboxyl
esterification 312, 313. Acetylation with acetic anhydride and pyridine was first developed by Verley
and Bolsing in 1901

314.

This reaction was not broadly applied until Steglich introduced 4-

dimethylaminopyridine (DMAP) and 4-pyrrolidinopyridine to catalyze the reaction in 1969 as
DMAP could speed up the reaction better than other bases due to its greater nucleophilicity 315, 316.
One year later the proposed mechanism was published by Fersht and Jencks, including the
formation of acetylpyridinium intermediate ion and subsequent acetyl transfer

317.

Kurahashi,

Mizutani and Yoshida then applied this approach to acetylate the hydroxyl groups of carbohydrate
and found that the 3- and 4-OH on glucopyranoside were more reactive than other positions 318.
The order of reactivity was slightly different for different types of carbohydrates. For
mannopyranoside, the order was 4-OH >6-OH>3-OH>2-OH while the order was 6-OH>4-OH 
3-OH>2-OH for galactopyranoside. Following the order of reactivity, the regioselective acylation
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was complete by DMAP catalysis 319. Moreover, the type of acylating reagent also had an impact
on reactivity, causing regioselectivity. For example, 4-OH was unreacted using acyl chloride while
4-OH acetylation was the main product using acetic anhydride 318, 320.
Acylation of GAGs has a long history to investigate the influence of acylation on functions
of GAGs. In 1947, Bell and Jaques first reported an acetyl derivative of Hp, which degraded
quickly in aqueous solution 321. In 1949, Bourne developed a mild method using carboxylic acid
and trifluoroacetic anhydride for acetylation of oligosaccharides resulting in a good yield 322. In
1988, Thomas group fully peracetylated HS tetrasaccharide using a mixture of trifluoroacetic
anhydride and acetic acid (2:1, v/v) and got the sequence information with fast-atom-bombardment
MS 323. As DMAP could significantly elevate the reaction rate over 105 times faster than that in
pyridine alone, Bendiak and Jones developed a peracetylation method of oligosaccharide with
DMAP in pyridine and acetic anhydride 324, 325. The conversion to triethylammonium salts was also
noticed by them to increase solubility during acetylation rather than sodium salts for sialylated
oligosaccharide-alditols. Most DMAP is volatile under the vacuum Speed-Vac concentrator (<50
milliTorr), simplifying the following purification process after the reaction. Besides the full
acylation, there are some reported site-specific acylations as well. For example, N-acetylation was
generally applied to protect the free amine from formation of quaternary ammonium after
desulfation but prior to methylation

289.

anhydride in methanol and acetic acid

N-acylation of chitosan was carried out with acetic

326.

N-propionylation of the group B meningococcal

polysaccharide was noticed to be bactericidal for group B meningococci by the use of propionic
anhydride in 2N sodium hydroxide at pH 9.5 327. Selective O-acylation of GAGs was performed
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on their tributyl- or tetrabutyl-ammonium salts with carboxylic acid anhydride as acylating agent,
DMAP as catalyst, dimethylformamide as solvent to study the impact of this modification on
biofunctions of GAGs 328.
Chemical derivatization has long been coupled with MS for structural sequencing of GAGs.
The glycosylation pattern of recombinant proteins can be reproducibly quantified after
permethylation with MALDI 329. Permethylation and preacetylation also improve the volatility of
GAGs and enable the GC-MS analysis 330, 331. Several groups have developed a high throughput
and robust MALDI-based MS profiling and CID MS/MS of permethylated glycans as the primary
screen in glycomics 279, 332, 333, 334. Chemical derivatization, especially permethylation with stable
epitope labelling, allows us to determine the sulfation pattern of highly sulfated GAGs with a
single stage CID MS/MS fragmentation 335.
The recent emergence of severe acute respiratory syndrome coronavirus in 2019 (Covid19) has created a global pandemic situation. There are many studies reported the essential role of
Hp/HS during viral infection 336, 337. Many viruses are first attached to the Hp/HS proteoglycans
on the extracellular, increasing the local viral amount and thus reaching the binding affinity with
specific receptor to infect the host cell. Since most glycan-protein interactions are involved in an
electrostatic interaction, the sulfation patterns may play an important role in viral attachment 338.
In Chapter 2, the impact of sulfation pattern of Hp/HS on COVID-19 attachment has been studied.
Hp and enoxaparin sodium are first either selectively desulfated or fully desulfated. The structurefunction relationship has been probed with the study of the inhibitory activity of Hp and enoxaparin
sodium derivatives on viral transduction. Our study shows that Hp, enoxaparin sodium and their
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6-O desulfated derivatives all have a potent anti-COVID-19 activity. A Hp nasal spray has been
proposed as a prophylactic treatment.
In Chapter 4, a new chemical derivatization is described, including propionylation and
desulfation. In this method, the original hydroxyl groups are first replaced by propionyl groups
and the newly formed hydroxyl or amine groups after desulfation reveals the initial sulfation
patterns. Following this derivatization approach, the sulfated GAGs could retain well on standard
reverse phase columns without ion pair agents and efficiently ionized under positive ion mode.
The sulfate amount on each carbohydrate ring could be resolved by a single CID MS/MS
fragmentation while the sulfation pattern on one ring could be further assigned by MS 3
fragmentation. For the first time, full pre-propionylation derivatization strategy has been
successfully applied to sulfated GAGs and been coupled with CID MS/MS for structural
sequencing of GAGs.
Approaches to characterize carbohydrate-protein interaction
Carbohydrate-protein interactions are mediated in numerous biological processes.
Characterization of carbohydrate-protein interactions is a necessity for us to understand the
mechanisms of these carbohydrates involved biofunctions. Recent characterization techniques are
introduced here, including nuclear magnetic resonance (NMR), surface plasmon resonance (SPR),
microarray and MS.
Nuclear magnetic resonance analysis
Solution NMR spectroscopy enables the study of glycan-protein interaction in solution
maintaining their dynamic behavior and provides fine atomic details 339, 340. Both saturation transfer
34

difference (STD) and transfer NOE (trNOE) NMR types depend on nuclear Overhauser effect
(NOE) and provide information about the ligand epitope and bound conformation 341.
The theory of NOE was first introduced by Albert Overhauser that if the electron spin
resonance of the conduction electrons is saturated, the nuclei will be polarized to the same degree
as that of the electron spin in 1953 342. STD-NMR is based on NOE and studies the resonance
signals of ligands when incubating them with as little as 1 nmol of protein in 1D and 2D NMR
spectra 343. In general, the spectrum was extracted in which protein was selectively saturated with
signal intensities ISAT and the other without protein saturation I0. In the difference spectrum (ISTD
= I0 - ISAT), only the ligand (s) received the saturation transfer from the protein will remain 344. The
non-binding ligands will not appear in the difference spectrum. As most of glycan-protein bindings
are weak (Kd values usually > 1 M) mainly via hydrophobic interactions to form hydrogen bonds
between glycans and aromatic amino acids, like tryptophan, STD shows great advantages in study
this low affinity interactions. There are many published reports using STD-NMR to investigate
protein-glycan binding. For example, STD-NMR has been used to study the binding of ABH blood
group with cholera toxin and clearly showed the interactions between each oligosaccharide and
cholera toxin B 345. STD-NMR has also been applied to dissect the structural requirements of the
glycans involved in the HIV/2G12 antibody interactions 346. Moreover, the intensity of signals
could differentiate the binding region of the small molecule from the non-binding region 347. The
glycan moieties involved in binding of threonine O-linked Thomsen-Friedenreich antigen have
been depicted by STD-NMR 348. A new gangliosides conformation was noticed to bind with the
innate immune regulator complement Factor H by STD-NMR
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349

. STD-NMR has a wide

application in the study of glycan-viruses interactions, such as influenza virus 350, adenovirus 351,
rotavirus 352 and norovirus 353. But the outcome of STD-NMR could only show the signal intensities,
which is not able to directly describe the 3D structure during interaction. A complete relaxation
and conformational exchange matrix-STD NMR method has been designed to overcome the
limitation and deliver the 3D view of interaction 354.
Transfer NOE-NMR is another excellent tool for determination of the glycan-protein
interactions. It monitors the proton resonance signals transferred from the spatial proximity of the
ligand protons in the bound state to those in the free ligands 355. The data from TrNOE-NMR
cannot only describe the contact sites between protein and glycan interactions, but also the
information about the bound conformations 356. Moreover, it can help determine the orientation of
the ligand in the receptor binding pocket. Usually, the experiments are required to incubate the
protein with different ligand ratios, ranging from 1:10 to 1:50, based on the size of the receptor
and the binding affinity. However, there is a main drawback of using TrNOE-NMR, which is
relevant to the spin diffusion effects for large molecules. Spin diffusion happens when the spin
magnetization is transferred through intermediate nuclei and becomes prominent at long mixing
times

357.

It could cause the increase in integral intensities of cross-peaks, resulting in

misinterpreted for large molecules, such as proteins. ROESY, which is using TrNOE in the rotating
frame, can solve the problem via spin diffusion effects and direct NOE enhancements 358.
There are many studies using TrNOE or ROESY to characterize glycan-protein interactions
359.

The bound conformations of langerin and sulfated GAGs in a Ca2+-independent way have been

determined by TrNOE-NMR, that the trimeric extracellular domain of langerin recognizes the
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major conformers of Hp-like trisaccharides in either 1C4 or 2SOconformation

360.

The bound

conformation of histo blood group antigens and noroviruses has also been identified by TrNOENMR, which is accordance with previous conformation in aqueous solution 361. The recognition of
a monoclonal antibody on mycobacterial lipoarabinomannan has been investigated by TrNOENMR 362.
An NMR-based strategy has been designed to characterize the N-glycan composition in
intact glycoproteins, the IgE high-affinity receptor expressed in human HEK 293 cells 363. In this
study, the presence and relative abundance of glycan epitopes are identified. The intramolecular
interactions between high-mannose N-glycans and the protein surface are also identified. For other
cases, even though N-glycans are not directly involved in interactions, motions of N-glycans could
allosterically effect the binding, demonstrated by NMR analysis 364. With progressively technology
development in NMR, solution NMR characterization of glycan-protein interactions will be more
promising.
Surface plasmon resonance analysis
Surface plasmon resonance (SPR) is an optical technique that measures the refractive index
change in a real-time manner 365. The general workflow includes following steps. First step is to
covalently link the reactant to the surface of sensor. In the second step, the other reactant in the
solution flows above the sensor surface at a constant flow rate. The formation of binding complex
on the sensor surface is monitored by the change of refractive index. Finally, the sensor chip is
regenerated after analysis. The basic mechanism of SPR was originally proposed by Kretschman
and Raether in 1968 366. The nonradiative surface plasmons coated with a metal film are excited
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with internal reflection of light. Waves of oscillating surface plasmons are formed and traveling
along the metal surface. The electromagnetic filed amplifies the light’s decay signal. Absorption
or desorption of binding molecules at the surface will change the local refractive index and show
a shift of resonance angle. There is a proportional correlation between the light shift and the surface
concentration of binding molecules 367. Following this theory, we will be able to screen out the
binding partners.
Considering the advantages of SPR, it has broad applications in glycan-protein interactions.
It has been applied to analyze the glycan-hemagglutinin on the influenza virus membrane
interactions, collecting precise kinetic parameters for different binding complexes

114.

The

screening of glycan-specific serum antibodies from S. mansoni-infected individuals has been
conducted with SPR including glycans of natural, and synthetic glycans 259. SPR binding assay
further investigates the binding between human milk glycans and two common norovirus strains.
The glycans show different binding preference towards each strain with SPR competitive binding
assays, suggesting their potential anti-adhesion during norovirus infection 368.
There is a main drawback of SPR technique. During SPR analysis, one of the binding
partners has to be immobilized on the sensor surface. For glycan-protein interactions, a library of
glycans are immobilized on the sensor chip in most cases. Unfortunately, most glycans do not have
a linker that can be immobilized on the chip. Reductive amination is frequently used to attach a
linker to the reducing end of glycans. The linker can be further covalently printed to epoxidecoated surfaces via the secondary amine published by De Boer’s group 369. However, through
reductive amination, the free reducing end of glycans is destroyed which will interfere the binding
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recognition involving the reducing end, such as the interaction between lysozyme and N, N′, N′′triacetylchitotriose

370.

To overcome this issue, some groups have investigated the direct

immobilization of large oligosaccharides onto the surface without modification, such as photoactive surfaces 371, 372.
The density of immobilized glycans also affects the SPR screening. For example, if the
printing solution is not homogeneous, there will be a density gradient within one spot after solvent
evaporation. The center of the spot has a lower or higher density compared to that in the border
region

373.

With certain attachment methods, especially non-covalent attachment, glycans can

move and generate density gradients within spot

374.

An alternative strategy is to covalently

immobilize glycans on the sensor surface with various concentrations. Multivalences of
glycodendrimers have been attached to an array surface and enabled the study of multivalence
effects on binding of lectins to mannose 375. Another study has found that different subpopulations
of antibodies recognize the same antigen with various glycan density 376. With the fast-technical
development in SPR biosensing platforms, undoubtedly, SPR will be a useful tool to advance the
study of glycan-protein interactions.
Glycan microarray analysis
Glycan microarray analysis is a high throughput screen technique to investigate the
interactions between glycans and target proteins. Glycan microarray is a powerful screening tool
that does not require the preliminary knowledge of glycan binding protein specificity like SPR, or
frontal affinity chromatography or isothermal calorimetry 377. Generally, a library of glycans are
first immobilized on the array surface, incubating with the increasing concentrations of a glycan39

binding protein. The binding information is based on the measurement of fluorescence emission
either from the fluorescent-tagged glycan-binding protein or from a secondary fluorescent
antibody 378.
Glycan microarrays were first introduced in 2002 by several groups 379, 380. Fukui’s study
demonstrated that the microarray technique from neoglycolipid was applicable to oligosaccharides
derived both from biological sources and from chemical syntheses. Wang’s paper suggested the
carbohydrate-based microarray could expand the study of viral anti-infection responses with
immobilized microbial antigens. From then on, there has been an explosion of research which
study the glycan-protein interactions with glycan microarrays 381, 382.
The size and diversity of glycan library have a significant impact on the microarray
screening. The screening from a larger and more diverse glycan library will reveal more biological
information. The number of cellular glycans is estimated over 100,000 to 500,000, which is not
feasible with current synthetic methodologies 383. Natural glycans isolated from natural sources
comprise the full natural diversity of glycans. However, it is challenging to isolate pure compounds
and verify their structures due to structural microheterogeneity. Also an extra chemical
derivatization is typically required for released glycan immobilization 97. That is why in Chapter
2, a three-dimensional separation method has been designed to isolate the natural glycans and an
AEAB conjugation is introduced for both enhancing separation/detection and immobilizing.
Overall, a glycan microarray is a powerful first-step screening that can be efficiently used to screen
over hundreds of glycans at the same time and provide lead compounds to further study 384.
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MS based analysis
Hydrogen-deuterium exchange MS is the method of measuring the exchange of amide
hydrogen in the backbone to deuterium by MS to indicate the conformation change of protein 385.
As deuterium is heavier than hydrogen, detecting the mass shift from hydrogen to deuterium by
MS is feasible as reported in 1991 386. The advantages of HDX include a low detection limit of
protein and no mass limit on protein, which is applicable to large proteins like monoclonal antibody.
HDX-MS based epitope mapping obtains the structure, dynamics, and interaction information of
proteins by comparing the deuterium incorporation amount over time 387. The principle is that when
an antigen is in a D2O solution, some of the hydrogens will undergo HDX following certain
exchange kinetics 388. When the antigen is incubated with antibody, the exchange rate can be
significantly decreased due to the reduction of solvent accessibility by steric hindrance 389, 390. Thus,
HDX is able to map the specific amino acid sequence involved in binding.
There are many studies investigating protein-protein interaction with HDX. The binding
between a monoclonal antibody against factor H binding protein has been characterized by peptide
arrays, phage display, X-ray crystallography, and HDX-MS

391.

Among them, HDX-MS is

regarded as the most effective method by the authors, rapidly showing more complete structural
information. HDX epitope mapping characterizes the interactions of 13 monoclonal antibodies
against GroEL found in Francisella tularensis, suggesting the protective effects are based on
structural stabilization in GroEL found in Francisella tularensis 392. There are also limitations of
HDX-MS analysis. Even though HDX occurs on every amino acids except proline, it cannot obtain
the exchange rate down to single amino acid level that cannot obtain the detailed structural
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information of protein folding or stability 393. Another main challenge is the back-exchange of
hydrogen and deuterium during digestion and HPLC separation 387. As deuterium incorporation is
non-covalent labeling, deuterium may easily fall off in the hydrogen rich solution, such as the
digestion buffer or LC mobile phase, yield 30% to 50% in total 388. Strategies have been designed
to overcome this issue, such as performing the relevant steps at 0C with a shorter LC method.
Fast photochemical oxidation of proteins (FPOP) is another approach to generate hydroxyl
radicals for hydroxyl radical protein footprinting (HRPF). HRPF is a MS based method developed
in 1999, which offers the topographical information of protein with covalent labeling at a single
amino acid resolution 394, 395. In 2005, Dr. Hambly and Dr. Gross developed FPOP for HRPF using
laser flash photolysis of hydrogen peroxide 396. With FPOP technique, it footprints the protein
faster than its unfolding

397.

Thus, it can determine protein structures and protein-ligand

interactions 398.
The applications of FPOP for characterizing protein-ligand interactions are growing
rapidly. Dr. Gross’s group has compared changing of protein conformation in the calmodulinpeptide model and established the unknown 3D structures via FPOP-MS 399. FPOP-MS could also
epitope map the protein-ligand interaction as HDX-MS or crystallography analysis demonstrated
by EGFR-adnectin 1 model 400. The glycan-protein binding interface can also be revealed by FPOP
401.

In the Hp-Roundabout 1 binding model, two binding interfaces have been identified by FPOP.

One is consistent with previous publications while the other one is disordered in the X-ray
crystallography, showing the strong characterization potential of FPOP in glycan-protein
interaction.
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There is no fast oxidation method to characterize the binding end of glycan with protein.
In Chapter 5, we design a fast-photochemical oxidation of carbohydrate (FPOC) method to screen
the protein-binding glycan from the glycan mixture with hydroxyl radicals. In this method, glycan
mixture is incubated with various protein solutions respectively and followed by FPOC, which
oxidizes the solvent accessible glycans and protein. Only the binding glycan in the corresponding
protein solution has a less solvent accessibility, showing the decrease of oxidation. By comparing
the oxidation change in reducing-end binding protein to the non-reducing end binding protein,
FPOC can also footprint the binding interface of glycan. Thus, FPOC can not only be a high
throughput screening technique as SPR or microarray, but can also be a footprinting approach as
FPOP.
Conclusions
This dissertation presents an in-depth approach for functional oligosaccharide analysis. In
Chapter 2, we will study the effects of Hp, enoxaparin and their derivatives on COVID-19
infection, which will broaden our understanding of these functional oligosaccharides. The threedimensional fractionation method designed in Chapter 3 will lower the structural complexity of
Hp/HS for further structural and functional studies by MS and microarray. The sulfation pattern
of functional oligosaccharides will be sequenced by the chemical derivatization method coupled
with tandem mass spectrometry designed in Chapter 4. In Chapter 5, a fast-photochemical
oxidation of carbohydrate method will enable the high throughput functional screening and reveal
the binding end of glycan during the interaction.
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CHAPTER II

EFFECTIVE INHIBITION OF COVID-19 ENTRY BY HEPARIN AND ENOXAPARIN
DERIVATIVES
Abstract
Severe acute respiratory coronavirus in 2019 (SARS-CoV-2) has caused a global pandemic
situation. In addition to its binding with specific receptor, the attachment and entry of SARS-CoV2 requires the interaction between the viral spike glycoprotein (SGP) and the proteoglycans on the
host extracellular membrane, especially heparan sulfate (HS). Here, we pseudotyped SARS-CoV2 SGP on a third-generation lentiviral (pLV) vector and tested the impact of various sulfated
polysaccharides on transduction efficiency in mammalian cells. The pLV vector pseudotyped SGP
efficiently and produced high titers on HEK293T cells. Various sulfated polysaccharides potently
neutralized pLV-S pseudotyped virus with clear structure-based differences in antiviral activity
and affinity to SGP. Concentration-response curves showed that pLV-S particles were efficiently
neutralized by a range of concentrations of unfractionated Hp (UFH), enoxaparin, 6-O-desulfated
UFH, and 6-O-desulfated enoxaparin with 50% inhibitory concentrations (IC50s) of 5.99mg/liter,
1.08mg/liter, 1.77mg/liter, and 5.86mg/liter, respectively. In summary, several sulfated
polysaccharides show potent anti- SARS-CoV-2 activity and can be developed for prophylactic as
well as therapeutic purposes.
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Introduction
In the late 2019, a novel coronavirus was reported in the city of Wuhan, China 402. The
virus quickly spread to the whole world and caused a global health emergency. WHO declared it
as a pandemic and named it as COVID-19 on February 11th, 2020 403, 404. There are over 30 million
coronavirus cases and 590 thousand deaths in the US. As the virus constantly mutates, there are
emerging new variants, causing more severe public health challenge. The variant, first detected in
UK and called B.1.1.7, could spread faster and cause a higher death rate 405. In late 2020, a new
variant called B.1.351 in South Africa is found to lower the efficacy of current vaccines 406. The
“double mutant” the B.1.617 variant is causing a second wave of pandemic in India 407. It is an
emerging need to inhibit the viral infection.
GAGs widely exist on the extracellular membrane and thus are involved in viral infection,
such as influenza virus, herpes simplex virus, and coronaviruses 408, 409, 410. GAGs could bind with
glycan-binding domains on the membrane of virus envelope, which will initiate the viral
attachment. This attachment will promote the viral binding with its protein receptors on the host
membrane and the following fusion and internalization

411.

Understanding the mechanism of

COVID-19 infection, especially the mechanism of interaction with GAGs may reveal new
approach to halt the pandemic.
HS are highly negatively charged GAGs that are covalently attached to the extracellular
membrane protein. There are several viruses required HS proteoglycans on the extracellular
membrane for adhesion, such as beta- and gamma-coronavirus, and infectious bronchitis virus 412,
413.

Moreover, adding in soluble HS could not only inhibit virus binding, but also reduce human

coronavirus NL63 replication in a dose-dependent, showing the great potential of using Hp/HS in
45

COVID-19 therapy 414, 415. But the structure-function relationship of HS in virus infection is not
clear due to the structural complexity. HS are widely distributed on the cellular membrane with
various length and sulfation patterns 416. The structures of HS are varied by the type of tissue or
cell and also dynamically changed during aging 417. The structural difference may explain the
influence of individual or age on susceptibility to virus. As the interactions are most mediated via
electrostatic interaction, sulfation pattern is recognized as the key structural characteristic on viral
inhibition 418.
In this study, we will study the effect of sulfation patterns on COVID-19 inhibitory. Hp
and enoxaparin sodium, a low molecular weight of Hp, will be partially desulfated at N- or 6-Oposition and fully desulfated through chemical derivatization. The selective desulfation will be
validate by NMR analysis. The COVID-19 inhibitory effect will be performed with a high-titer
lentivirus pseudotyped with viral spike glycoprotein.
Experimental
Materials
Enoxaparin sodium injection (Winthrop/Sanofi, Bridgewater, NJ, USA) was used as
provided. HS sodium salt from bovine kidney, Hp sodium salt from porcine intestinal mucosa
(molecular weight

419,

18kDa), N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA), and

Dowex 50WX8-100 ion-exchange resin were purchased from Sigma-Aldrich Inc. (St. Louis, MO,
USA). Chondroitin sulfate sodium salt was purchased from Santa Cruz Biotechnology, Inc. (Dallas,
TX, USA). For SPR studies, Arixtra (Mw = 1,727 Da) was purchased from Pharmaceutical Buyers,
Inc. (New Hyde Park, NY), porcine intestinal heparan sulfate (HS) (Mw = 14 kDa) was from
Celsus Laboratories (Cincinnati, OH), chondroitin sulfate A (CS-A) (Mw = 20 kDa) from porcine
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rib cartilage was from Sigma (St. Louis, MO), dermatan sulfate (DS) (Mw = 30 kDa) from porcine
intestine was from Sigma, chondroitin sulfate C (CS-C) (Mw = 20 kDa) from shark cartilage was
from Sigma, chondroitin sulfate D (CS-D) (Mw = 20 kDa) from whale cartilage was from
Seikagaku (Tokyo, Japan), and chondroitin sulfate E (CS-E) (Mw = 20 kDa) from squid cartilage
was from Seikagaku. Keratan sulfate (KS) was prepared from bovine cornea as previously
described

420.

Nonanticoagulant low-molecular-weight HP (NACH) was synthesized from

dalteparin, a nitrous acid depolymerization product of porcine intestinal HP, followed by periodate
oxidation 421. Nonanticoagulant Hp TriS (NS2S6S) was synthesized from N-sulfo heparosan with
subsequent modification with C5-epimerase and 2-O- and 6-O-sulfotransferases (2OST and
6OST1/6OST3) 422. Hp oligosaccharides included tetrasaccharide, hexasaccharide, octasaccharide,
decasaccharide,

dodecasaccharide,

tetradecasaccharide,

hexadecasaccharide,

and

octadecasaccharide and were prepared from porcine intestinal UFH via controlled partial Hp lyase
1 treatment followed by size fractionation. Sensor SA chips were from GE Healthcare (Uppsala,
Sweden). SPR measurements were performed on a Biacore 3000 system operated using Biacore
3000 control and BIAevaluation software (version 4.0.1). CF680R dye was purchased from
Biotium Inc. (Fremont, CA, USA).
Hp and enoxaparin sodium desulfation for pseudotyped virus inhibiton.
Prior to desulfation, UFH and enoxaparin sodium were first converted to their pyridinium
salts by passing through a self-packed cation-exchange column with Dowex 50 W resin, followed
by lyophilization

335.

For N-desulfation, 1mg pyridinium salts was resuspended in 1 ml 5%

methanol in dimethyl sulfoxide (DMSO) and heated at 50°C for 1.5 h. The sample was diluted and
purified with a 3-kDa Amicon Ultra centrifugal filter (Millipore, Temecula, CA, USA) to remove
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low-molecular-weight impurities 308. For 6-O-desulfation, 1mg pyridinium salts was added to 10
volumes (wt/wt) of MSTFA and 100 volumes (vol/wt) of pyridine. The mixture was incubated at
100°C for 30 min and then quickly cooled in an ice bath 423. The sample was dried under nitrogen
gas flow and purified with a 3-kDa Amicon Ultra centrifugal filter (Millipore, Temecula, CA, USA)
to remove low-molecular-weight impurities. Selectively desulfated products were analyzed by
proton NMR to determine the extent and specificity of desulfation as detailed below. For full
desulfation, 1mg pyridinium salts was resuspended in 1 ml 10% methanol in DMSO and heated at
100°C for 6 h 424. The fully desulfated products were dried and administered as pyridinium salts
for further studies.
Synthesis of near-infrared fluorophore-labeled Hp
The Hp-CF680R was generated by conjugating the free reducing-end of Hp with the aminooxy
group of the CF680R. Briefly, 5 nmol Hp in 100 L phosphate buffered saline (pH 7.4) was added
to 50 molar equivalents of CF680R in water. To catalyze the reaction, 3000 molar equivalents of
aniline in 15 L acetate buffer (pH4.5) was further added. The reaction mixture was incubated at
room temperature over-night and purified by a 3 kDa Amicon Ultra centrifugal filter (Millipore,
Temecula, CA, USA) to remove low molecular weight impurities. It was analyzed by HPLC SEC
column (4.6 mm × 300 mm, 1.7 µm, Waters) using a Dionex UltiMate 3000 LC system (Thermo
Fisher Scientific).
Results and Discussion
The four Hp derivatives were subjected to one-dimensional (1D) 1H NMR analysis together with
the unmodified standards to confirm the selective removal of sulfation at the N- and 6-O positions
of the a-GlcN,6diS units in UFH and low-molecular-weight Hp (LMWH) after the reactions.
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FIGURE 2.1. 1D 1H NMR SPECTRA OF (A) UFH, (B) UFH-DENS, (C) UFH-DE6S, (D) LMWH, (E) LMWH-DENS,
AND (F) LMWH-DE6S (EXPANSION H, 7.0 TO 0.4 PPM).

The signals which were diagnostic for the desulfation reaction are labeled with letters and numerals according to the
monosaccharide types, positions of the protons within the sugar rings, and 6-sulfation (6S) or non-6-sulfation (6nS).
The letters A, B, C, D, E, and I denote, respectively, a-GlcN,6diS, a-GlcNAc(6S), a-GlcN6S, a-GlcNAc, a-GlcNS,
and a-IdoA2S. The 6-sulfation in the a-GlcNAc(6S) cannot be ensured solely on the basis of the anomeric assignment
(signal B1).

Figure 2.1 illustrates the resultant spectra in which characteristic peaks were assigned and
labeled to straightforwardly recognize the structural integrity of each sample. As expected, the two
peaks assigned as 6S belonging to the two protons in the C-6H2OSO3- site present H at the
downfield region close to 4.2 ppm (spectra in Fig. 2.1A, B, D, and E), while the peak labeled as
6nS with H at the more upfield region between 3.6 ppm and 3.7 ppm (spectra in Fig. 2.1C and
F) is typical of the non-6-sulfated site of the glucosamine unit. This confirms that the 6-O49

desulfation reaction occurred successfully for samples UFH-de6S (Fig. 2.1C) and LMWH-de6S
(Fig. 2.1F), respectively, and that this type of sulfation was maintained as original in all other Hp
samples. As a consequence of the 6-O-desulfation, the anomeric 1H signals of GlcNAc (assigned
as D) and GlcNS (assigned as E) became resolved in the spectra of the UFH-de6S and LMWHde6S samples, while the major A1 peak of the GlcN,6diS clearly seen in the spectrum of the
controls and the 2-O-desulfated versions disappeared. Note also that the A2 and E2 peaks with H
close to 3.2 ppm of the unmodified standard and 6-O-desulfated Hps are at the same place,
indicative of N-sulfation. This indicates that the 6-O-desulfation reaction was very selective, acting
only on the 6-O-sulfation sites, and did not cause any unexpected removal on the N-sulfation sites
of the same glucosamine units in the Hp derivatives. Similarly, to the displacement of the NMR
signals related to 6-O-sulfation, the 2-O-desulfation caused a shift solely of the A2 peaks (H close
to 3.2 ppm) from the original positions on the UFH and LMWH samples to the new upfield position
of d H close to 3.3 ppm, as indicated by the labeled signal C2 in the UFH-deNS (Fig. 2.1B) and
LMWH-deNS (Fig. 2.1E). This shift is indicative of stereospecific desulfation at the N position.
The unchanged peaks labeled as 6S on these Hp versions clearly confirm that the 6-O-sulfation
was preserved after the selective N-desulfation reaction. The peaks labeled as B1 and C1 belong
to anomers of the glucosamine units which are unsulfated at the N position. Note that these peaks
show distinct H of the original A1 signals in the Hp standards and of the E1 signals of both the
UFH-6deS and LMWH-6deS samples, which are all N-sulfated.
As shown in Figure 2.2, Hp and enoxaparin inhibit viral attachment. Selective desulfation
at the 6-O position of GlcN did not significantly reduce inhibitory activity of either Hp or
enoxaparin. Complete desulfation of both UFH (UFH-fully-deS) and enoxaparin (enoxaparin50

fully-deS) greatly decreased anti-SARS-CoV-2 activity. Similarly, selective N desulfated Hp and
enoxaparin show decreased inhibitory activity. Our data suggest that 6-O-sulfation is not required
for anti-SARS-CoV-2 activity in a pseudotyped transduction model. Similar binding preference
has also been found with other proteins, such as human fibroblast growth factor – 1 (FGF-1) and
interleukin-10 that N-desulfation significantly decreases the interaction compared to 6-Odesulfation

425, 426.

The decrease in binding may due to the exposure of primary amine, which is

positively charged under physiological condition and causes repulsion with cationic protein
residues. The desulfation on either N- or 6-O position changes the critical charge density and the
spatial distribution of charge, which thus affects the total number of interactions 427.
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FIGURE 2.2. SARS-COV-2 SGP PSEUDOTYPED LENTIVIRAL SCREEN FOR INHIBITION OF ATTACHMENT AND ENTRY.
(A) Quantitation of GFP-transduced cells in the presence of each inhibitor at three concentrations. Average GFP
transduction of control was 200.2 cells per well. (B) Representative fluorescence microscopy of the UFH-deNS
inhibitor assay. (C) Representative fluorescence microscopy of the UFH inhibitor assay.
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As Hp inhibit viral attachment and entry, nasal administration of Hp as a prophylactic
against COVID-19 infection shows great potential. The main concern is the pharmacokinetics of
Hp clearance from the nasal cavity. To test the lifetime of Hp in the nasal cavity, Hp was first
labeled with a near-IR chemical dye (CF680R) at the reducing end. As shown in Figure 2.3, the
labeled Hp (eluted around 20 min) could be detected under two UV wavelength (232 nm and 728
nm), suggesting the successful labeling. Intranasal administration of CF680R-Hp in a female
SKH1-Elite mouse resulted in intense fluorescent signal as shown in Figure 2.4. In vivo imaging
showed accumulation and residence in the nasal cavity, with clearance via the stomach and
intestine.

FIGURE 2.3. NEAR-IR DYE LABELED HP.
SEC chromatogram of labeled Hp under two wavelength, 232 nm and 728 nm.
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FIGURE 2.4. IN VIVO IMAGING OF 1.67 µG OF NASALLY ADMINISTERED CF680R-HP.
In vivo imaging shows accumulation and residence in the nasal cavity, with clearance via the stomach and intestine.

Conclusion
Based on pseudotyped system, we found that Hp, enoxaparin sodium and their 6-Odesulfated derivatives could all inhibit the viral transduction, the potential COVID-19 antiviral
treatment.
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CHAPTER III

A MULTI-DIMENSIONAL HPLC FRACTIONATION METHOD ENABLES THE
STRUCTURE-FUNCTION ANALYSIS OF DIVERSE HEPARIN/HEPARAN SULFATE
OLIGOSACCHARIDES BY MS AND MICROARRAY
Abstract
Hp and heparan sulfate (Hp/HS) are linear complex glycosaminoglycans which are
involved in diverse biological processes. The structural complexity brings difficulties in separation,
making the study of structure-function relationships challenging. Here we present a multidimensional separation method for Hp/HS oligosaccharide fractionation with cross-compatible
solvent and conditions, combining size exclusion chromatography (SEC), ion-pair reversed phase
chromatography (IPRP), and hydrophilic interaction chromatography (HILIC) as three orthogonal
separation methods that do not require desalting or extensive sample handling. With this method,
the final eluent is suitable for structure-function relationship studies, including tandem mass
spectrometry and microarray printing. Our data indicate that high resolution is achieved on both
IPRP and HILIC for Hp/HS isomers. In addition, the fractions co-eluted in IPRP could be further
separated by HILIC, with both separation dimensions capable of resolving some isomeric
oligosaccharides. We demonstrate this method using both unpurified reaction products from
isomeric synthetic hexasaccharides and an octasaccharide fraction from enoxaparin, identifying
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isomers resolved by this multi-dimensional separation method. We demonstrate both structural
analysis by MS, as well as functional analysis by microarray printing and screening using a
prototypical Hp/HS binding protein: basic-fibroblast growth factor (FGF2). Collectively, this
method provides a strategy for efficient Hp/HS structure-function characterization.
Introduction
Hp/HS are glycosaminoglycans (GAGs), highly anionic unbranched polysaccharides
found on the surface of essentially all mammalian cells. Hp/HS consists of a repeating disaccharide
structure either β-D-glucuronic or α-L-iduronic acid (GlcA and IdoA, respectively) and α-D-Nacetyl-D-glucosamine (GlcNAc), all connected by 1→4 linkages 428. As a part of biosynthesis,
monosaccharides can be differentially N- and O-sulfated after polymerization. Since these
modifications are incomplete and untemplated, there is enormous structural heterogeneity in
Hp/HS chains, including many isomeric structures with widely varying and dynamic compositions
429.

Different cell types will often display different HS structures, and these structures can change

as part of the cell’s physiological response 78. Hp/HS has been involved in a wide and growing
array of physiological and pathophysiological processes, usually mediated through interactions
between proteins and a subset of Hp/HS structures

430, 431, 432.

While the importance of

oligosaccharide structure has been established in many functions of Hp/HS, understanding the
structures that underlie any of the various functions is highly challenging. Two technologies that
have been applied with considerable success in understanding Hp/HS structure-function
relationships are mass spectrometry (MS) 433, 434 and Hp/HS microarrays 435, 436. However, the vast
diversity, myriad isomeric structures, and difficulties in separation make the application of these
tools towards Hp/HS oligosaccharides very challenging. The vast diversity of potential structures
(5.3 million octasaccharides) makes complete coverage by synthetic methods impractical
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437

.

Therefore, the need for efficient separation technique prior to MS or microarray printing that is
readily compatible with these techniques is clear 144, 438.
Low molecular weight Hp (LMWH) is a partially depolymerized product of Hp. In the
U.S.A., the most widely used LMWH is enoxaparin sodium, which is generated by β-elimination
of Hp 439. The majority of the depolymerization products have a 4,5-unsaturated dehydro-uronic
acid residue (UA) at the non-reducing end, which can be detected at 232 nm by a UV detector
440.

Enoxaparin sodium is a good model for the study of separation and characterization of Hp/HS

with high-performance liquid chromatography (HPLC). Normally, size exclusion chromatography
(SEC) is the first separation method following partial depolymerization of the Hp/HS
polysaccharide 119. Most methods of Hp/HS depolymerization cleave to the non-reducing end of
the uronic acid, resulting in oligosaccharide products that differ by a disaccharide unit in length
and can be separated by SEC based on the oligosaccharide length

127.

A common follow-up

separation is a charge-based separation, strong anion exchange chromatography (SAX), which has
a high resolving power for Hp/HS fractionation 441. However, the high concentration of sodium
chloride (normally 1.0 M) used in SAX makes it incompatible with MS or other forms of
chromatography that use organic solvents 442. Thus, the isolated components after SAX must be
desalted prior to MS or further separation, causing sample loss compared to the limited sample
amount.
Ion-pair reversed phase chromatography (IPRP) is another powerful method for Hp/HS
fractionation with the addition of ion-pairing agents, such as pentylamine 162 or tributylamine 165.
Compared with SAX, IPRP is more easily coupled with other separation methods and MS.
Hyphenation of IPRP with SEC and time of flight mass spectrometry have greatly improved
separation and provided more complete and important structural information of low molecular
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weight Hp (LMWH) 99. The ion-pair agents will easily induce in-source contamination and cause
signal suppression when coupled with MS. Some IPRP agents can also interfere with microarray
immobilization schemes 443. Reverse-phase chromatography without the use of strong ion pairing
reagents (RP) has also shown strong separation ability for heavily derivatized chondroitin sulfate
isomers and HS 335, 444, but the derivatization process leaves the oligosaccharides in non-native
conditions not suitable for further functional analysis. Thus, a more MS- and microarray-friendly
orthogonal separation method for native oligosaccharides is preferred to couple with IPRP.
Hp/HS are very hydrophilic with several polar groups, like sulfates, carboxylates, and
hydroxyls. HILIC has been widely used for the chondroitin sulfate (CS), dermatan sulfate (DS),
and Hp/HS separation 445, 446, 447. Because HILIC requires only volatile mobile phase components
and a pH range readily compatible with LC-MS analysis, it is particularly useful for sample
cleanup prior to MS in order to provide further detailed structural analysis 448. The orthogonality
of IPRP and HILIC separation has been illustrated for N-linked glycans, suggesting the potential
power of this hyphenation into a multi-dimensional LC scheme for Hp/HS 98.
The structural variability of Hp/HS is responsible for interactions between Hp/HS and a
wide variety of proteins 449. The fibroblast growth factors (FGFs) are the most thoroughly studied
proteins, which bind to the extracellular matrix by interacting with Hp/HS

450, 451.

Tetra- and

hexasaccharides are sufficient to bind FGF2 with high affinity 452. The 2-O-sulfate iduronate and
the N-sulfate of glucosamine are critical motifs for FGF2 binding. Carbohydrate microarrays are
powerful high-throughput screening platforms to discover Hp/HS-proteins interactions 97. The use
of microarrays of fractionated Hp/HS will substantially improve the understanding of Hp/HSprotein interactions.
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Here we present a multi-dimensional separation method for Hp/HS oligosaccharide
fractionation (Figure 3.1) with solvent and separation conditions that are both readily crosscompatible, as well as a final eluent that is amenable to both electrospray (ESI)-MS and microarray
immobilization. This method uses SEC, followed by pentylamine/acetic acid IPRP
chromatography, and ending with amide-HILIC. These hyphenated HPLC separations increase
resolving power, bridge Hp/HS MS structural analysis and microarray functional studies, and are
readily compatible with online or offline ESI-MS. Our data highlights the advantages of SECIPRP-HILIC for separation and purification of complex mixtures of Hp/HS, establishing this
methodology as a useful tool for efficient and high-resolution Hp/HS fractionation.

FIGURE 3.1. MULTI-DIMENSIONAL SEPARATION WORKFLOW.
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Data shown are taken from this study to represent the value of each step. A.) SEC separation of the partially
depolymerized Hp/HS, enoxaparin sodium; B.) chemo-selective reductive amination of one SEC fraction (dp8) with
AEAB; C.) IPRP separation of AEAB-labeled oligosaccharide SEC fraction (dp8); IPRP fractions could be either
analyzed by D.) online HILIC LC/MS (IPRP fraction RT 35 to 36 min shown); or E.) separated by offline HILIC with
fractions collected (IPRP fraction RT 36.8 to 38 min shown); F.) microarray immobilization of HILIC fractions and
protein binding affinity assay.

Experimental
Materials
Enoxaparin sodium injection (Winthrop/Sanofi, Bridgewater, NJ, USA) was used as
provided. 2-amino-N-(2-aminoethyl)-benzamide (AEAB) was purchased from Chem-Impex
International (Wood Dale, IL, USA). Water was purified by a MilliQ ® system (Millipore, Bedford,
MA, USA). Ammonium formate and sodium cyanoborohydride were purchased from Thermo
Fisher Scientific (Waltham, MA, USA). Glacial acetic acid, dimethyl sulfoxide (DMSO), formic
acid, and pentylamine were purchased from Millipore Sigma (St. Louis, MO, USA). All chemicals
used were at least of analytical grade. Three hexasaccharides with unsaturated uronic acid at the
non-reducing end were chemically synthesized using modified reported procedures and the
reaction products were desalted over a Bio-Gel P-2 column (Bio-Rad®, Hercules, CA, USA)
without further purification; the detailed synthetic methodology will be reported elsewhere. The
expected synthetic structure of U-H-1 is ∆4,5UA-GlcNS6S-GlcA-GlcNS6S3S-IdoA2S-GlcNS6S;
U-H-2 is ∆4,5UA-GlcNS6S-IdoA2S-GlcNS3S-IdoA2S-GlcNS6S; U-H-3 is ∆4,5UA-GlcNAc6SGlcA-GlcNAc6S3S-IdoA2S-GlcNAc6S. Recombinant human fibroblast growth factor basic was
purchased from R&D Systems, Inc. (Minneapolis, MN, USA). Rabbit anti-FGF-2 antibody was
purchased from Abcam (Cambridge, MA, USA). Goat anti-rabbit Cy5 antibody was purchased
from Life Technologies (Carlsbad, CA, USA).
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Size exclusion chromatography (SEC)
SEC separation was performed on a chromatographic column packed with P-10 media
(Bio-Rad®, 45-90 µm) and collected by a Frac-920 fraction collector (GE Healthcare Life Sciences,
Chicago, IL, USA). 100 mg of commercial Enoxaparin Sodium Injection was injected onto the
SEC column and separated by using 0.5 M ammonium bicarbonate eluent at a flow rate of 0.2
mL/min. GAG oligosaccharide quantities were measured using a NanoDrop TM 2000
spectrophotometer (Thermo Fischer Scientific) at a detection wavelength of 232 nm. Fractions
from each peak were pooled and evaporated with dry nitrogen gas flow.
Preparation of AEAB oligosaccharide derivatives
The enoxaparin sodium size-fractionated samples were re-dissolved with water and acetic
acid. 0.4 M AEAB in DMSO and 1 M sodium cyanoborohydride in DMSO were added. The ratio
of DMSO and acetic acid was varied with acetic acid contents of 10%, 20%, 30% and 40% v/v
tested, with 40% acetic acid used as an optimized condition. The mixture was then incubated at
37 °C overnight and dried with nitrogen gas. The dried sample was resuspended in water/methanol
(80:20, v/v). It was analyzed and purified by HPLC SEC column (4.6 mm × 300 mm, 1.7 µm,
Waters) using a Dionex UltiMate 3000 LC system (Thermo Fisher Scientific) following the
method of Dr. Zaia and coworkers 129. Based on high-resolution SEC separation of derivatized IIS disaccharide standard, the reductive amination reaction had a yield of ~99% at 40% acetic acid
(data not shown). Fractions were collected with an online auto-sampler and further dried down
with nitrogen gas. Each synthetic hexasaccharide followed the same protocol.
Ion-pair reverse phase chromatography (IPRP)
IPRP separations were performed on a Dionex UltiMate 3000 LC system (Thermo Fisher
Scientific) using a C18 column (150 mm × 2.1 mm, 2.6 µm, Kinetex®, Phenomenex), with a UV-
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visible spectrophotometric detector. Phase A was 95% water and 5% acetonitrile and phase B was
acetonitrile. The ion-pairing agents were 20 mM pentylamine (PTA) and 20 mM acetic acid. All
chromatographic separations were monitored at both 232 nm and 260 nm wavelengths. The
separation gradient started with 10% B for 5 min, ramped to 20% B and held for 10 min, followed
a linear gradient from 20% to 29% B over 65 min, changed to 50% B over 5 min, washed with 50%
B for 25 min, then changed to 10 % B over 1 min and re-equilibrated for 24 min. The flow rate
was 0.1 mL/min. The column temperature was 40 °C. Fractions were collected with an online autosampler and further dried under the nitrogen gas flow.
Amide hydrophilic interaction chromatography (HILIC)
HILIC was performed on a BEH Amide HILIC column (50 mm × 1 mm, 1.7 µm,
ACQUITY UPLC® BEH Amide, Waters). The flow rate was set to 0.1 mL/min. The gradient for
hexasaccharide analysis started with 90% B for 5 min, with a linear gradient down to 30% B over
60 min, held at 30% B for 4 min and finally washed with 10% B for 10 min and re-equilibrated
with 90% B for 10 min. The gradient for octasaccharide analysis started at 75% B for 5 min, with
a linear gradient from 75% B to 30% B over 60 min, held at 30% B for 4 min and finally washed
with 10% B for 10 min and re-equilibrated with 75% B for 10 min. Buffer A was 10 mM
ammonium formate (pH 4.4, adjusted with formic acid) and buffer B was 98% acetonitrile with 2%
buffer A for online LC-MS analysis. Buffer A was 50 mM ammonium formate (pH 4.4, adjusted
with formic acid) for microarray fractionation.
Online LC-MS method and MS data analysis
The fractionated samples after IPRP were analyzed by LC-MS on a Thermo Orbitrap
Fusion Tribrid (Thermo Fisher Scientific) coupled with a Dionex UltiMate 3000 liquid
chromatography (Thermo Fisher Scientific) using a BEH Amide HILIC column (50 mm × 1 mm,
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1.7 µm, ACQUITY UPLC® BEH Amide, Waters). The oligosaccharides were analyzed in negative
ion mode with the ESI voltage set to 1.8 kV. Full mass scan range was set to 230-1000 m/z at a
resolution of 60000, and the automatic gain control (AGC) target was set to 1 × 10 5 counts. The
datasets generated during and/or analyzed during the current study are available from the
corresponding author on reasonable request. GlycoWorkbench software was used to interpret the
possible compositions of Hp/HS oligosaccharide ion signals. To interpret the MS data with
GlycoWorkbench, we set searching constraints based on the biosynthetic rules of Hp. The
maximum value of dehydro-hexuronic acid was set to 1 while the maximum value for hexuronic
acid and hexosamine were both set to 5. The maximum number of sulfate groups was 24 and the
maximum number of acetate groups was 5. The reducing end delta mass was selected as a mass
value of 163.1 Da for the AEAB label. Compositions are reported according to a modified version
of the bracketed nomenclature of Dr. Zaia and coworkers [A, B, C, D, E, F], where A is the number
of dehydro-uronic acid monosaccharides, B is the number of uronic acid monosaccharides, C is
the number of glucosamine monosaccharides, D is the number of sulfations, E is the number of
acetylations, and F is the number of AEAB labels in the identified composition 129.
Microarray printing, binding assay, and scanning
The arrays were constructed using the guidelines v 1.0. provided by the Minimum
Information for a Glycomics Experiment Project (MIRAGE) as reported here 453.
Fractions (126) after off-line HILIC separation were printed on NHS-ester activated glass
slides (NEXTERION® Slide H, Schott Inc.) using a Scienion sciFLEXARRAYER S3 non-contact
microarray equipped with a Scienion PDC80 nozzle (Scienion Inc.). Individual samples (5 nmols)
were dissolved in sodium phosphate buffer (50 µL, 0.225 M, pH 8.5) at a concentration of 100 µM
and were printed in replicates of 6 with spot volume ~ 400 pL, at 20°C and 50% humidity. Each
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slide has 24 subarrays in a 3x8 layout. After printing, slides were incubated in a humidity chamber
for 8 hours and then blocked for one hour with a 5 mM ethanolamine in a Tris buffer (pH 9.0, 50
mM) at 50°C. Blocked slides were rinsed with DI water, spun dry, and kept in a desiccator at room
temperature for future use.
Printed glass slides were incubated with premixed solution of recombinant human
fibroblast growth factor basic (1.0 to 0.25 µg/mL FGF-2), rabbit anti-FGF-2 antibody (1:300) and
goat anti-rabbit Cy5 antibody (1:300) at room temperature in the dark. After 1h, the slide was
sequentially washed by dipping in TSM wash buffer (2 min, containing 0.05 % Tween 20), TSM
buffer (2 min) and, water (2 x 2 min), spun dry. The slides were scanned using a GenePix 4000B
microarray scanner (Molecular Devices) at the appropriate excitation wavelength with a resolution
of 5 µm. Various gains and PMT values were employed in the scanning to ensure that all the
signals were within the linear range of the scanner’s detector and there was no saturation of signals.
The image was analyzed using GenePix Pro 7 software (version 7.2.29.2, Molecular Devices).
The data was analyzed with our home written Excel macro to provide the results. The
highest and the lowest value of the total fluorescence intensity of the six replicates spots were
removed, and the four values in the middle were used to provide the mean value and standard
deviation.
Results and Discussion
The structural complexity of Hp/HS is preserved during AEAB conjugation
To optimize the LMWH sample for both UV detection and microarray immobilization, we
used 2-Amino-N-(2-aminoethyl) benzamide (AEAB) as a reducing-end tag 454. In order to ensure
we preserved the structural complexity of Hp/HS during AEAB conjugation, we employed the Hp
disaccharide standard II-S to develop optimized labeling conditions and validate the chemo-
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selectivity under the optimized conditions. Hp disaccharide II-S AEAB conjugate was prepared
under various amounts of acetic acid and analyzed by HILIC LC-MS. As the amount of acetic acid
increased from 10% to 40%, the main product was shifted from conjugation through the aliphatic
amine (IIS-AEAB1) to conjugation through the arylamine (IIS-AEAB2, Figure 3.2). At lower pH,
the aliphatic amine was protonated and its nucleophilicity would decrease significantly, leaving
the unprotonated arylamine to react to with the reducing end of Hp disaccharide II-S to form II-SAEAB2 conjugate. Therefore, a selective AEAB conjugate is formed with 40% acetic acid, leaving
the aliphatic amine free for use in microarray immobilization chemistry. To further confirm the
selectivity of the reaction, the synthesized hexasaccharide isomers were labeled under the
optimized conditions. The results from HILIC-MS showed that there was only one conjugate LC
peak for each isomer under 40% acetic acid (Figure 3.3). This indicated that the conjugation
between the aromatic amine and the reducing end of the sugar was the only detectable product at
40% acetic acid derivatization conditions, excluding the possibilities of introducing isomers during
the reductive amination reaction.
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FIGURE 3.2.CHEMO-SELECTIVITY OF REDUCTIVE AMINATION OF HP/HS WITH AEAB.
A.) Scheme of AEAB reductive amination. The difference in pKa between the aromatic amine and the aliphatic amine
achieves selective reactivity by controlling the reaction pH. B.) Extracted ion chromatogram of Hp disaccharide II-S:
AEAB conjugate after reaction in different concentrations of acetic acid (v/v). The earlier eluting peak represents
conjugation of AEAB through the aliphatic amine, with the desired conjugation product through the aromatic amine
eluting later.

66

FIGURE 3.3. AMIDE-HILIC LC-MS EXTRACTED ION CHROMATOGRAM (EIC) DATA FOR EACH AEAB LABELED
SYNTHETIC HEXASACCHARIDE ISOMER.

With optimized conditions, there is only one labeled product for each synthetic hexasaccharide.
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Validation of multi-dimensional separation method with synthetic hexasaccharides
We obtained three synthetic hexasaccharides in an unpurified state to evaluate the multidimensional separation method, focusing on the separation of isomeric hexasaccharides in a
moderately complex background. The expected synthetic structure of U-H-1 is ∆4,5UA-GlcNS6SGlcA-GlcNS6S3S-IdoA2S-GlcNS6S; U-H-2 is ∆4,5UA-GlcNS6S-IdoA2S-GlcNS3S-IdoA2SGlcNS6S;

U-H-3

is

∆4,5UA-GlcNAc6S-GlcA-GlcNAc6S3S-IdoA2S-GlcNAc6S.

Each

hexasaccharide was first characterized by amide-HILIC LC-MS and a complex background was
detected due to the partial product GAGs in the reaction. The synthetic hexamers were AEABlabeled with 40% acetic acid, the optimized condition as described above. These AEAB-labeled
synthetic hexasaccharide products were separately injected onto the C18 column with ion-pairing
agents so that the retention times (RTs) of three labeled hexaccharides could be confirmed (Figure
3.4), with the UV trace-based assignments confirmed by HILIC-MS as described below.
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FIGURE 3.4. IPRP ANALYSIS

OF

AEAB-LABELED

UNPURIFIED SYNTHETIC HEXASACCHARIDES INJECTED

SEPARATELY.

The U-H-1-AEAB was mainly eluted after 24 min while U-H-2-AEAB was mainly eluted between 22 to 23 min. Nacetylated hexamer U-H-3-AEAB eluted earlier than either isomer.

U-H-3-AEAB (a labeled hexasaccharide with five sulfate groups and three acetyl groups)
eluted between 19 min and 20 min. Two isomeric hexasaccharides with eight sulfate groups and
no acetyl group, U-H-1-AEAB and U-H-2-AEAB, were separated by IPRP. U-H-2-AEAB eluted
between 22 min and 23 min while U-H-1-AEAB eluted between 25 min and 26 min. This overall
elution pattern was consistent with IPRP elution order, where lower sulfated oligosaccharides elute
earlier. To validate the multi-dimensional separation method, the mixture of three labeled synthetic
hexasaccharide products was initially separated by IPRP (Figure 3.5),
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FIGURE 3.5. IPRP

CHROMATOGRAM OF

AEAB

LABELED SYNTHETIC HEXASACCHARIDE MIXTURE WITH

UV

DETECTION AT (BLUE) 232 NM AND (ORANGE) 260 NM.

After labeling with AEAB, these synthetic hexasaccharides were separated on IPRP. Peaks were initially assigned
based on the elution time of the major peak in the individual synthetic reaction product (Supplementary Information
Figure S5). HILIC LC-MS data from fractions shown in black, red, and green are shown in Figure 3.6.

and fractions of isomeric hexamers were collected and subsequently separated by online amideHILIC LC-MS. LC-MS displayed two peaks with an [M -4H]4- ion of m/z 452.5 corresponding to
the [1,2,3,8,0,1] (labeled isomeric composition) from two IPRP fractions (RT 22 to 23 min & RT
25 to 26 min) (Figure 3.6). In the extracted ion chromatograms (EICs), one isomer in IPRP RT 22
to 23 min fraction was eluted at 27.1 min on amide-HILIC, which was U-H-2-AEAB.
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FIGURE 3.6. THE

EXTRACTED ION CHROMATOGRAMS OF

[M -4H]4-

ION CORRESPONDING TO

AEAB-LABELED

[1,2,3,8,0,1] FROM IPRP FRACTIONS.
The EICs have shown that the derivatized hexasaccharide composition [1,2,3,8,0,1] collected from IPRP in the 22 to
23 min fraction (top) eluted from the HILIC column around 27.1 min, while the same composition from the IPRP 25
to 26 min fraction (bottom) eluted around 28.0 min on HILIC. The IPRP 23 to 24 min fraction contains the shoulders
of both isomer peaks in the IPRP chromatogram, and by HILIC (middle) both the 27.1 and the 28 min peak are partially
resolved.

The other isomer in IPRP RT 25 to 26 min fraction was eluted at 28.0 min on amide-HILIC,
which was U-H-1-AEAB. Both isomers were co-eluted on IPRP from 23 to 24 min. The AEAB
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labeled isomers were not only separated by IPRP (RT 22 to 23 min vs. 25 to 26 min) but LC-MS
of the IPRP fraction collected in the valley of the two unresolved isomeric peaks (RT 23 to 24 min)
displayed two resolved peaks on HILIC-MS. This result demonstrated the ability of HILIC to
separate isomers with distinct sulfate positions under the conditions used here. Overall, IPRP
coupled with amide-HILIC not only exchanges solvent to more compatible volatile one for MS
sequencing, but also provides high-resolution separations in each dimension for Hp/HS
oligosaccharides.
SEC-IPRP-HILIC separation of enoxaparin sodium
To further evaluate the multi-dimensional separation method, we applied the method to a
more complex starting material, enoxaparin sodium. Enoxaparin sodium is a degraded product of
Hp; hence it is a good model for highly complex sulfated oligosaccharides derived from natural
sources. Due to the multi-dimensional structural complexity of enoxaparin sodium (chain length,
sulfate number, and sulfation pattern), size exclusion chromatography was introduced as the firstdimension separation to lower the complexity of size. We employed a size-defined octasaccharide
fraction to further validate the multi-dimensional separation method.
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The octasaccharide SEC fraction of enoxaparin sodium was derivatized with AEAB under
optimized

conditions

and

then

subjected

to

IPRP

chromatography

(Figure

3.7).

FIGURE 3.7. SEPARATION OF AEAB LABELED ENOXAPARIN OCTASACCHARIDES USING IPRP DETECTED USING 232
NM (BLUE TRACE) AND 260 NM (ORANGE TRACE) WAVELENGTHS.

The heterogeneous enoxaparin octasaccharide fraction separated into many poorly-resolved peaks across the elution
window. The four fractions highlighted in the chromatogram were collected for further HILIC separation and MS
analysis as examples.

Four diverse fractions from the IPRP chromatogram were selected and separately injected
onto the amide-HILIC column. The top four possible octasaccharide compositions in each IPRP
fraction were analyzed by GlycoWorkbench and listed in Table 3.1.
IPRP fraction (Retention Time)

Oligosaccharide composition†
[1,3,4,6,1,1]

27-28 min

[1,3,4,6,2,1]
[1,3,4,7,1,1]
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[1,3,4,8,0,1]
[1,3,4,7,1,1]
[1,3,4,8,1,1]
35-36 min
[1,3,4,8,2,1]
[1,3,4,9,1,1]
[1,3,4,8,1,1]
[1,3,4,9,1,1]
40-41 min
[1,3,4,10,1,1]
[1,3,4,10,0,1]
[1,3,4,11,0,1]
58-61 min
[1,3,4,12,0,1]

TABLE 3.1. MOST ABUNDANT COMPOSITIONS OF AEAB LABELED OCTASACCHARIDES FROM MULTI-DIMENSIONAL
SEPARATION.
†

Oligosaccharide compositions are given as [∆HexA, HexA, GlcN, SO 3, Ac, AEAB].

For the same octasaccharide compositions (e.g. [1,3,4,8,1,1]), the signal was detected in
two disparate IPRP fractions (35 to 36 min and 40 to 41 min), which also had different retention
times on amide-HILIC (27.84 min vs. 19.69 min) (Figure 6). Interestingly, the huge difference in
retention times (RT=5 min on IPRP and RT=8 min on amide-HILIC) indicated that a very high
resolution was achieved with the multi-dimensional separation method. Similar isomeric
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separations

could also be found for

[1,3,4,7,1,1]

a.

and [1,3,4,9,1,1]

(Figure 3.8).

b.

FIGURE 3.8. THE EICS OF ENOXAPARIN DP8 IPRP FRACTIONS .
a. The EICs of [1,3,4,7,1,1] from enoxaparin dp8 (top) IPRP 27-28 min fraction and (bottom) 35-36 min fraction; b.
The EICs of [1,3,4,9,1,1] from enoxaparin dp8 (top) IPRP 35-36 min fraction and (bottom) 40-41 min fraction.

Thus, oligosaccharide composition analysis demonstrated that the powerful multidimensional separation method was able to resolve complex isomeric structures, especially sulfate
positional isomers.
Although IPRP itself could separate simple isomers, it may not be sufficient for complex
mixtures like Hp/HS. In order to examine the possible advantages of adding in an amide-HILIC
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dimension, we examined extracted ion chromatograms of various compositions from the surveyed
IPRP fractions on HILIC LC-MS as shown in Figures 3.9.

b.

a.

FIGURE 3.9.THE HILIC EICS OF [M -4H]4- ION CORRESPONDING TO [1,3,4,8,1,1] FROM IPRP FRACTIONS.
A.) In the IPRP 35 to 36 min fraction, this composition eluted at 27.8 min. B.) In the IPRP 40-41 min fraction, a
different structure with this composition is eluted at 19.7 min. b. The EICs of the top four octasaccharide compositions
from the IPRP 35-36 min fraction. The octasaccharides, which are not separated by IPRP, are resolved by HILIC,
including two clearly separated [1,3,4,8,2,1] isomers, illustrating orthogonality between HILIC and IPRP
chromatography. Oligosaccharide compositions are given as [∆HexA, HexA, GlcN, SO3, Ac, AEAB].

For some compositions such as [1,3,4,8,2,1], two isomers co-eluted in IPRP (both in 35-36 min
fraction) but were separated on HILIC (26.8 min vs. 32.4 min) (Figure 3.9). This indicated that
the multi-dimensional separation method could provide higher resolution than the one-dimensional
separation method for Hp/HS. Additionally, the eluent is completely volatile, making buffer
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exchange convenient with very little sample loss. Overall, the data validated that the multidimensional separation method had a high resolution for Hp/HS, and effectively eliminated ion
pairing reagents from the buffer simultaneously.
The application of the multi-dimensional separation method for microarray functional studies
As a further test of the application of the multi-dimensional separation method, we probed
fractions for binding to FGF2. All FGFs have a high affinity for Hp/HS and the affinity of FGF is
modulated by different Hp/HS structures 455. Therefore, this assay would identify which highly
enriched fractions had a higher affinity to FGF2 and demonstrate the compatibility of the multidimensional separation method with amine-mediated microarray immobilization.
We employed the multi-dimensional separation method described above to lower the
structural complexity gradually and constructed Hp/HS oligosaccharide fraction microarrays for
functional study, starting with the octasaccharide fraction from SEC. More than 40 fractions were
collected from the IPRP run (starting from retention time 24 min to 77 min). HILIC separation
was performed for each IPRP fraction, with each peak collected as a fraction and lyophilized.
Using AEAB absorbance to quantify oligosaccharide concentration (using a calibration curve
based on AEAB-labeled Hp disaccharide), 5 nmol of each eluent fraction was aliquoted out and
diluted in appropriate buffer to yield a printing concentration of 100 M 453. Together with three
controls [AEAB labeled enoxaparin sodium octasaccharides (in duplicate), and synthetic
octasaccharide], 129 highly enriched oligosaccharide fractions were printed in replicates of 6 on
NHS-ester activated glass slides, generating a series of Hp/HS octasaccharide microarrays.
Through multi-dimensional separations, some octasaccharide fractions (Sample No. 52, 58, 65,
and 85) had a higher affinity to FGF2 with higher fluorescence signal while some octasaccharide
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fractions (Sample No. 53, 55, 60, and 70) had low affinity to FGF2 with lower fluorescence signal
(Figure 3.10 and Figure 3.11).

FIGURE 3.10. THE FGF2 BINDING AFFINITY ASSAY OF 129 FRACTIONS OF ENOXAPARIN DP8.
The blocks from left to right are binding affinities under various FGF2 concentrations, A). 1 µg/mL, B). 0.5 µg/mL,
and C). 0.25 µg/mL, respectively. Fractions from No. 1 to No. 126 were eluents from the multi-dimensional separation
method. Detail information of each fraction was listed in Table S1. Fractions No. 127 & 128 were unfractionated
octasaccharide. Fraction No. 129 was synthetic octasaccharide (IdoA2S-GlcNS6S repeat) as a positive control.
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FIGURE 3.11. FGF2-BINDING ASSAY ON HP/HS OCTASACCHARIDE-AEAB MICROARRAY.
Each fraction is printed in replicates of 6 in a single block with droplet volume around 400 pL. Fractions from the
multi-dimensional separation method are directly applicable to microarray study. Based on the fluorescent intensity
of each spot, it indicates that each fraction has different binding affinities to FGF2. Fractions from No. 1 to No. 126
were eluents from the multi-dimensional separation method. Fractions No. 127 & 128 were unfractionated
octasaccharide. Fraction No. 129 was synthetic octasaccharide as a positive control.
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FIGURE 3.12. CORRELATION

BETWEEN

IPRP

RETENTION TIME,

HILIC

RETENTION TIME, AND

FGF2

BINDING

RESPONSE.

A strong correlation between HILIC retention time and FGF2 binding is apparent, indicating that FGF2 is binding
ligands that are more highly sulfated. No correlation between IPRP retention time and FGF2 binding is apparent.

Analysis of FGF2 binding versus retention time by IPRP and HILIC reveals a strong
correlation between HILIC retention and FGF2 binding (Figure 3.12). Previous work by Zaia and
coworkers have shown that amide-HILIC retention time is dominated by acetyl and sulfate
composition for Hp/HS oligosaccharides of a given size 456, indicating that FGF2 binding increases
as sulfate content increases. This is consistent with previous microarray results using synthetic
oligosaccharides that showed that FGF2 binds all highly sulfated GAG tetrasaccharides well, while
intermediately sulfated structures showed a clear structure-function relationship

176,

and is

consistent with other FGF2 binding structure-function studies showing preference for high
sulfation and indicating the importance of 2-O-sulfation and N-sulfation to FGF2 binding 436, 452,
457, 458.

Although Hp/HS influence numerous physiological and pathophysiological processes,
their high degree of size polydispersity and sequence microheterogeneity make the structure-
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function characterization challenging. In most modern cases, structural analysis is limited to
compositional analysis, with oligosaccharide sequences rarely addressed from complex mixtures.
Here we demonstrate a three-dimensional LC separation method, SEC-IPRP-HILIC, that is applied
for the efficient analysis of Hp/HS with high resolution separation of isomeric sequences,
compatibility with both on-line and off-line MS structural analysis and microarray functional
analysis.
We have shown that IPRP and HILIC offer orthogonal selectivity with a resolution that
can, at least in some cases, separate positional isomers that differ by the site of modification and
possibly uronic acid stereochemistry (which was not directly probed in this study), with an
overview of the contribution of each step demonstrated in Figure 3.1. Although IPRP itself could
separate Hp/HS isomers, our data demonstrate incomplete separation of some isomers, indicating
that extra separation is needed to resolve more detailed structural information in Hp/HS. For the
first time, clean HILIC separation of isomeric Hp oligosaccharides is demonstrated, as shown in
Figure 3.9-a for composition [1,3,4,8,1,1] and octasaccharide compositions [1,3,4,7,1,1] and
[1,3,4,9,1,1] among others. Each separation dimension adds resolution to the overall separation, in
addition to HILIC serving as a desalting step to remove ion pairing reagents from IPRP fractions.
We also demonstrate the compatibility of the multi-dimensional separation method to
glycan microarray analysis. The fractions from HILIC are directly compatible with microarray
immobilization. Ammonium formate, acetonitrile and water used in our HILIC method are volatile
and does not interfere with the immobilization method and allows buffer exchange by evaporation
or lyophilization, with very little sample loss. Glycan microarrays permit the study of specific
Hp/HS-binding proteins quantitatively even with a very limited amount. AEAB incorporates
stoichiometrically to oligosaccharides by specific reductive amination to provide both increased
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UV detection sensitivity and a reactive group for immobilization, and only 1 to 2 nmols of AEABlabeled Hp/HS fractions are required to prepare microarrays. Our unfractionated octasaccharide
microarray results (Sample No. 127 & No. 128) showed lower binding than our fractions with
highest activity, confirming that multi-dimensional separation does not compromise the binding
capability of the oligosaccharides. As anticipated, the microarray data also display clear diversity
in binding affinities of each fraction (Figure 3.10), consistent with the intermediate structural
specificity of FGF2 binding to Hp/HS oligosaccharides 416, 459, 460. Although Hp/HS separated by
the multi-dimensional separation method might have similar compositions, both their separation
and diverse binding affinities indicate that they are structurally and functionally different. It is
possible that the unique structures or composition motifs binding with FGF2 are separated from
unbinding Hp/HS fractions. While AEAB-labeling and microarray analysis provide powerful
options for structure-function analysis, this method will also work for salt-free fractionation of
depolymerized oligosaccharides without derivatization of the reducing end, so long as the
unsaturation at the non-reducing end is present to provide a chromophore or some other LC
detection method is available.
Conclusions
Overall, this multi-dimensional separation method provides high-resolution separation of
Hp/HS and thus generate Hp/HS microarrays for functional study with high purity. The ability to
perform HILIC-MS directly allows investigators to directly couple structural interrogations with
functional analysis. Future studies will couple this separation method with more detailed Hp/HS
structural interrogation methods that determine precise sites of sulfation

424, 444, 461,

which are

usually lost in MS/MS analysis. In addition, such Hp/HS microarrays will be useful for screening
more Hp/HS-binding proteins and will permit the discovery of new protein-carbohydrate
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interactions. Thus, this method is invaluable in recognizing complex protein-carbohydrate
interactions and is also essential to reveal functional Hp/HS structures as novel biomaterials or
therapeutics.
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CHAPTER IV

PERACYLATION COUPLED WITH TANDEM MASS SPECTROMETRY FOR
STRUCTURAL SEQUENCING OF SULFATED GLYCOSAMINOGLYCAN MIXTURES
WITHOUT DEPOLYMERIZATION
Abstract
The structures of glycosaminoglycans (GAGs), especially the patterns of modification, are
crucial to modulate interactions with various protein targets. It is very challenging to determine
the fine structures using liquid chromatography-mass spectrometry (LC-MS) due in large part to
the gas-phase sulfate losses upon collisional activation. Previously, our group reported a method
for fine structure analysis that required permethylation of the GAG oligosaccharide. However,
uncontrolled depolymerization during the permethylation process due to esterification of uronic
acid lowers the reliability of the method to resolve structures of GAGs, especially for larger
oligosaccharides. Here we describe a simplified derivatization method using propionylation and
desulfation. The oligosaccharides have all hydroxyl and amine groups protected with propionyl
groups, then have sulfate groups removed to generate unprotected hydroxyl and amine groups at
all sites that were previously sulfated. This derivatized oligosaccharide generates informative
fragments during CID that resolve the original sulfation patterns. This method is demonstrated to
enable accurate determination of sulfation patterns of even the highly sulfated pentasaccharide
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fondaparinux by MS2 and MS3. Using a mixture of dp6 from porcine Hp, we demonstrate that
this method allows for structural characterization of complex mixtures, including clear
chromatographic separation and sequencing of structural isomers, all at high yield without
evidence of depolymerization. This represents a marked improvement in reliability to structurally
characterize GAG oligosaccharides over permethylation-based derivatization schemes.
Introduction
Glycosaminoglycans (GAGs) are linear polysaccharides which are usually covalently
linked to the protein forming proteoglycans (PGs). GAGs are present on the cell surface and in the
extracellular matrices (ECMs) of almost all mammalian cells 462. Based on the differences in the
repeating disaccharide building blocks, GAGs are typically separated into five classes: hyaluronan
(HA), keratin sulfate (KS), chondroitin sulfate (CS), dermatan sulfate (DS), and Hp/HS 33. The
disaccharide motif of Hp/HS is comprised of either -D-glucuronic or -L-iduronic acid (GlcA
and IdoA, respectively) and -D-N-acetyl-D-glucosamine (GlcNAc) connected by 1→ 4 linkages.
The uronic acid (UA) can be 2-O-sulfated and epimerized, while the GlcN can be 3-O-sulfated, 6O-sulfated, N-deacetylated and/or N-sulfated 463. While Hp and HS share the same backbone repeat,
they differ by both protein core (HS is found on many proteins and virtually all mammalian cells,
while Hp is solely found on serglycin in mast cells and some hematopoietic cells) and the extent
of modification (Hp is typically more heavily sulfated with more iduronic acid, while HS is more
heterogeneous)

464.

These modifications are incomplete and untemplated during biosynthesis,

making Hp/HS the most structurally complex member of GAG family 465. The high degree of
heterogeneity makes separation and structural sequencing a very challenging task.
Interactions between GAGs and proteins are involved in a wide range of physiological and
pathophysiological processes, including cell signaling, tumor progression and viral attachment and
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entry 84, 408, 466, 467, 468. It is widely believed that GAG polysaccharides with specific sulfation
patterns play important roles in many of these bio-processes. For example, not only the total
amount but also the amount of specific sulfation of Hp/HS are significantly decreased in renal
tumor tissue, which promotes tumor growth, invasion and stimulates angiogenesis 467. Therefore,
the structural sequencing of functional active oligosaccharides rather than just disaccharide
composition analyses is essential to understand the functions of GAGs and design novel
therapeutics based on these interactions.
Mass spectrometry (MS) and nuclear magnetic resonance (NMR) are two powerful
analytical tools to resolve the detailed structural information 214, 469. The application of NMR is
usually limited by the low sensitivity, requiring significant amounts of pure oligosaccharide for
fine structure assignment

100.

In contrast, the advantages of MS are often more desirable for

sequencing of these highly heterogeneous mixtures, with a high sensitivity and direct compatibility
with on-line liquid chromatography (LC) separations 470 and capillary electrophoresis 471. There
are several MS compatible LC separation methods that have been used to analyze GAG
oligosaccharides, including SEC, HILIC, PGC and IPRP 128, 144, 164, 448. The complexity of Hp/HS
could be simplified prior to MS analysis using on-line separation

101.

However, accurate

sequencing of the sulfation patterns of oligosaccharides remains a major challenge in the fine
structural characterization of Hp/HS oligosaccharides using MS and MS 2.
Collisional induced dissociation (CID) is by far the most prominent method of tandem
mass spectrometry

472.

However, CID usually results in extensive sulfate loss

473.

Several

pioneering manuscripts have been published to address this issue. Amster and co-workers have
stabilized the liable sulfate groups via Na+/H+ exchange to get informative glycosidic and crossring fragment ions 109. However, the conditions, especially deprotonation and combination with
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on-line LC separation, need to be optimized for each sulfated GAG making it very difficult to use
in a general experimental method. Other ion activation methods have been applied to the fine
structural characterization of Hp/HS including negative electron transfer dissociation (NETD),
electron detachment dissociation (EDD) and recently ultraviolet photodissociation (UVPD) 236, 474,
475, 476.

Questions remain regarding the robustness of these techniques, and some of these

dissociation techniques are not currently commercially available, but they remain promising
methods of dissociation for underivatized GAG oligosaccharides.
In our previous reports, we have designed a chemical derivatization method coupled with
tandem mass spectrometry for structural analysis of Hp/HS oligosaccharides using standard C18
chromatography coupled to CID MS/MS 335, 444, 477, 478. This method involves a permethylation
protection step, gentle desulfation by solvolysis, and pertrideuteroacetylation to label sites of
sulfation. The derivatized Hp/HS oligosaccharides are separated by C18 reversed phase LC (RPLC)
and sequenced by CID MS/MS analysis, allowing fine sequence identification using only
glycosidic bond cleavages. With this sequencing method, we could observe sufficient fragment
ions to resolve the sequence and have first identified a Robo1-specific Hp/HS octasaccharide
sequence 479. We recently improved the method’s ability to sequence mixed NS/NAc domains by
replacing the trideuteroacetylation with propionylation, allowing us to separate tetrasaccharide
isomers that differed by the placement of NS/NAc groups

477.

While these methods could

successfully sequence mixtures of small oligosaccharides, formation of the uronic acid methyl
ester promotes cleavage of the glycosidic bond through β-elimination, especially under conditions
required for high permethylation yield 480. In order to more reliably sequence these essential GAGs,
we present an approach here that prevents depolymerization side reactions while still offering high
reaction yields.
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FIGURE 4.1. CHEMICAL DERIVATIZATION WORKFLOW.
To enhance solubility in THF, Arixtra was first converted to its TEA salt by passing through a cation exchange resin,
followed by propionylation with propionic anhydride. After propionylation, derivatized Arixtra was converted to its
pyridinium salt. Sulfates were removed with solvolytic desulfation, leaving sites of sulfation marked by free hydroxyl
or amine groups.
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As shown in Figure 4.1, this method consists of an initial acylation protection step,
installing propionyl groups on all non-sulfated/non-acetylated amine and alcohol positions. After
solvolytic desulfation, the positional information of the original sulfation pattern will be
represented by the newly formed hydroxyl or amine groups. The derivatized analyte can be wellretained on C18 RPLC and sequenced via MS2 and MS3. This methodology provides a more robust
option for the fine structure analysis of longer GAG oligosaccharides using commonly available
commercial LC-MS systems.
Experimental
Materials
Fondaparinux sodium (Arixtra) was purchased from Mylan Inc. (Canonsburg, PA, USA).
Sep-Pak C18 Plus Short cartridges (360 mg Sorbent per cartridge, 55-105 µm particle size, 50/pk)
were purchased from Waters (Milford, MA, USA). Enoxaparin sodium injection (Winthrop/Sanofi,
Bridgewater, NJ, USA) was used as provided. Triethylamine (TEA) was purchased from Fisher
Scientific (Hampton, NH, USA) while tetrahydrofuran (THF) was purchased from VWR
International, LLC (Radnor, PA, USA). 4-(Dimethylamino) pyridine (DMAP), propionic
anhydride and Dowex 50WX8-100 ion-exchange resin were purchased from Sigma-Aldrich Inc.
(St. Louis, MO, USA). Water was purified by a MilliQ system (Millipore, Bedford, MA, USA).
All other regular chemical reagents used in the chemical derivatization were purchased from
Sigma-Aldrich Inc. (St. Louis, MO, USA).
Propionylation of HA dp10
Three nmols of dried hyaluronic acid (HA) dp10 were resuspended in 72 µL toluene, 8 µL
of DMAP in toluene (1 µg/µL) was added, followed by addition of 0.8 µL TEA and 20 µL
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propionic anhydride. The reaction was incubated at 25 °C for 2 days. The reaction was stopped by
adding 1 mL methanol and dried under nitrogen gas flow. The propionylated HA dp10 was
resuspended in water at a concentration of 1 µg/ µL. The sample was analyzed by HPLC SEC
column (4.6 mm × 300 mm, 1.7 µm, Waters) using a Dionex UltiMate 3000 LC system (Thermo
Fisher Scientific) following the method of Zaia and coworkers 129. UV detection was carried out
at 232 nm.
Chemical Derivatization of Arixtra
To increase its solubility in THF, Arixtra was converted to triethylamine (TEA) salts by
passing through a self-packed cation-exchange column with Dowex 50 W resin, followed by
lyophilization. The dried TEA salts (11 µg) were resuspended in 500 µL THF and added 160 µL
DMAP in THF (12 µg/ µL) followed by addition of 19 µL TEA and 108 µL propionic anhydride.
The reaction was incubated at 45 °C for 4 days. The reaction was stopped by adding 1 mL methanol.
The propionylated products were dried and then purified with a 3 kDa Amicon Ultra centrifugal
filter (Millipore, Temecula, CA) to remove the excess amount of DMAP and propionic anhydride
Although the molecular weight of Arixtra is below 3 kDa, it has reported that any size of the Hp/HS
sample larger than tetrasaccharide does not pass through the 3 kDa membrane 481. The purified
products were made as pyridinium salts using the same cation-exchange resin and dried again as
reported. The pyridinium salts were dissolved in 10% methanol in dimethyl sulfoxide (DMSO)
and incubated for 6 h at 100 °C to remove the sulfates 477. The desulfated products were dried and
resuspended in water at a concentration of 0.2 µg/ µL for analysis.
Yield estimation by HILIC LC-MS
As there is no chromophore on Arixtra for UV quantification, HILIC LC-MS was used to
estimate the propionylation yield for Arixtra. The derivatized products were analyzed by LC-MS
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on a Thermo Orbitrap Fusion Tribrid (Thermo Fisher Scientific) coupled with a Dionex UltiMate
3000 liquid chromatography (Thermo Fisher Scientific). Buffer A was 10 mM ammonium formate
(pH 4.4, adjusted with formic acid) and buffer B was 98% acetonitrile with 2% buffer A. Online
HPLC was performed on a BEH Amide HILIC column (50 mm × 1 mm, 1.7 µm, ACQUITY
UPLC® BEH Amide, Waters). The flow rate was set to 0.1 mL/min and a 3 µL injection at a
sample concentration of 0.2 µg/ µL. The gradient started with 90% B for 5 min, with a linear
gradient down to 30% B over 60 min, held at 30% B for 4 min and finally washed with 10% B for
10 min and re-equilibrated with 90% B for 10 min. The theoretical mass for each degree of
substitution was generated via ChemDraw Professional software (version 16.0, PerkinElmer
Informatics). The yield was estimated based on the peak area of the extracted ion chromatogram
(EIC) of each product from HILIC-MS. This quantification method inherently assumes equal
ionization efficiencies of all products, and should be viewed as semi-quantitative.
Chemical derivatization of Hp dp6 mixture
A Hp hexasaccharide (dp6) mixture was collected by SEC separation. Briefly, 100 mg of
commercial Enoxaparin Sodium Injection was injected onto the in-house packed P-10 SEC column
(Bop-Rad, 45-90m), separated with 0.5 M ammonium bicarbonate, and the dp6 fraction was
collected using a Frac-920 fraction collector (GE Healthcare Life Sciences, Chicago, IL, USA).
The dried dp6 (50 ug) was converted to TEA salts as described above for Arixtra. The dried TEA
dp6 salts were resuspended in 650 L THF and 5 mg of DMAP were added, followed by addition
of 48 L TEA and 1 mL propionic anhydride. The reaction was incubated at 45 °C for 4 days. The
reaction was stopped by adding in methanol and purified with a 3kDa filter. The solvolytic
desulfation process was completed as described above for Arixtra. The desulfated products were
further dried and resuspended in water for LC-MS/MS analysis.
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Structural sequencing with LC-MS/MS and LC-MS3 analysis
Online HILIC LC-MS was performed for hexasaccharide composition analysis of the
enoxaparin dp6 mixture prior to derivatization. The detailed method for HILIC-MS was identical
to that described for Arixtra yield estimation. A theoretical mass list was generated manually to
identify selected compositions using Xcalibur.
For LC-MS/MS and MS3, all samples were analyzed on a Thermo Orbitrap Fusion Tribrid
(Thermo Fisher Scientific) coupled with a Dionex UltiMate 3000 liquid chromatography (Thermo
Fisher Scientific). The reverse-phase separation was performed on a C18 PepMap 100 trap column
(15 mm × 0.3 mm, 5 µm, Thermo Fisher Scientific) with an Acclaim PepMap 100 C18 column
(15 cm × 75 µm, 2 µm, Thermo Fisher Scientific). Buffer A was 0.1% formic acid in water, and
buffer B was 0.1% formic acid in acetonitrile. The flow rate was set to 0.25 µL/min. To sequence
Arixtra, a 30 min gradient started at 20% B for 4 min, elevated to 70% at 4.5 min, with a linear
gradient up to 98% B over 10.5 min, held at 98% B for 5 min and re-equilibrated with 20% B for
10 min. To sequence dp6, a 60 min gradient started at 20% B for 4 min, with a linear gradient to
98% B over 26 min, held at 98% B for 20 min and re-equilibrated with 20% B for 10 min. The
derivatized products were analyzed in positive ion mode with the nanoelectrospray voltage set to
2.6 kV. Full MS scan range was set to 150-800 m/z at a resolution of 60000. RF lens was 6% and
the automatic gain control (AGC) target was set to 1.0 × 105. For the MS/MS scans, the resolution
was set to 15000, the precursor isolation width was 3 m/z units and ions were fragmented by
collision-induced dissociation (CID) at a normalized collision energy of 40%. For the MS 3 scans
for Arixtra, the resolution was set to 15000, the precursor isolation width was 2 m/z units and ions
were fragmented by collision-induced dissociation (CID) at a normalized collision energy of 25%.
Annotation of MS/MS spectra were carried out using the nomenclature of Domon and Costello 213.
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–P represents neutral loss of C3H4O; -PA represents neutral loss of C3H6O2; -OMe represents
neutral loss of CH4O.
Results and Discussion
The purpose of the chemical derivatization strategy is to protect the initial hydroxyl and
free amine groups via an acylation reaction, and then remove all labile sulfate groups to leave free
hydroxyl and/or amine groups only where the sulfates used to be as shown in Figure 4.1. Original
sites of sulfation can then be identified by a lack of acylation in MS/MS. In order to differentiate
naturally occurring GlcNAc from GlcN labeled during the acylation step, propionylation is used
for the protection chemistry. After MS/MS, the original sites of sulfation can be determined based
on the lack of propionyl groups on the monosaccharide.
Propionylation of HA dp10
The major drawback to our previously published derivatization scheme for sequencing
GAG oligosaccharides was uncontrolled depolymerization, which increased with increasing
oligosaccharide length. In order to test the ability to fully propionylate GAG oligosaccharides
without the undesirable depolymerization previously identified with permethylation, we
propionylated dp10 of hyaluronic acid (HA) and used SEC LC-UV detection to identify any
depolymerization products. As shown in Figure 4.2, HA dp10 undergoes permethylation-induced
depolymerization due to esterification of the glucuronic acid. Because of the relatively
homogeneous size, HA dp10 allows us to screen our optimized acylation methodology to
determine if it also results in depolymerization of the long oligosaccharide.
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(a)

(c)

(b)

FIGURE 4.2. SEC-UV CHROMATOGRAMS OF A. UNMODIFIED HA DP10, B. HA DP10 PERMETHYLATED AT PH 6~7,
AND C. HA DP10 PERMETHYLATED AT PH 9~10.

With the increasing pH of permethylation, the size of HA dp10 was significantly decreased. At pH 9~10, there was
no detectable intact HA dp10 shown on SEC chromatogram, demonstrating depolymerization during permethylation.
The arrow represents the retention time of full-length HA dp10 on SEC.

FIGURE 4.3. SEC

CHROMATOGRAMS OF A. REACTION

BLANK WITH NO HA DP10, B. UNMODIFIED HA DP10, AND
C. FULLY PROPIONYLATED HA DP10.

SEC chromatograms of a. reaction blank with no HA dp10,
b. unmodified HA dp10, and c. fully propionylated HA
dp10 with UV detection at 232 nm, respectively. After
propionylation, there was only one GAG peak with a similar
peak shape and retention time as the unmodified HA dp10.
The SEC chromatogram demonstrated no depolymerization
of HA dp10 during propionylation.

As shown in Figure 4.3, the SEC HPLC
chromatogram showed that after propionylation,
the derivatized HA dp10 had a similar retention time as the underivatized sample. No evidence of
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depolymerization is evident in the acylated HA dp10, while depolymerized HA dominated the
permethylated dp10 SEC chromatogram under both conditions tested.
Chemical derivatization of Arixtra
Unlike unsulfated HA, the high amount of sulfate and carboxyl groups made sulfated
GAGs highly negatively charged. They also often form sodium salts, which prevents the complete
dissolution in less polar solvents

335.

Arixtra is often used to represent a challenging GAG

oligosaccharide for methods development, as it has a very high sulfate density (eight sulfates in a
pentasaccharide), has a non-repetitive structure, and includes an uncommon 3-O-sulfation which
has been shown to be more labile to high pH in some analyses 482. The polarity of the solvent had
a large effect on the yield of acylation, with the rate of reaction accelerated in the less polar solvent.
In order to solubilize highly-sulfated Arixtra in a non-polar solvent, Arixtra was converted to a
TEA salt prior to propionylation 269, 335. Even so, the highly sulfated TEA-Arixtra salts could not
dissolve well in the toluene solvent used for HA propionylation. A prior report used THF as the
solvent for acetylation 419, and the Arixtra-TEA salts dissolved well in this solution. The widely
accepted mechanism for acylation is through the nucleophilic attack of DMAP at the anhydride
carbonyl group and subsequent formation of the corresponding acyl-pyridinium cation. This cation
reacted with the hydroxyl groups and yielded the final product, fully propionylated Arixtra 316. The
auxiliary base, TEA, was necessary to regenerate the protonated catalyst after the reaction. Thus,
the amount of DMAP and TEA were important parameters for full propionylation. For the
optimized protocol used here, the yield of full propionylation of Arixtra (+6 propionyl groups) was
estimated to be 86% with most of the losses in the form of singly-underpropionylated (<10%) and
singly-desulfated, singly-overpropionylated (<4%) products (Table 4.1). Permethylation was one
of the most well-established chemical derivatization methods used in MS sequencing. However,
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the reported yields of full permethylation was low due primarily to depolymerization and work-up
losses: approximately 30% for HS dp4 mixtures 478 and less than 50% for Arixtra 480. Without using
sodium hydroxide in the reaction, propionylation avoids depolymerization 269. Together with a
high yield and no depolymerization, propionylation shows advantage over permethylation.
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Peak area
Arixtra

298,050

1 propionyl

0

2 propionyl

0

3 propionyl

20,357

4 propionyl

107,968

5 propionyl

3,443,061

6 propionyl

32,296,024

7 propionyl (Losing one sulfate
group

and

with

an

extra

1,389,975

propionyl group)
8 propionyl

0

9 propionyl

0

10 propionyl

0

11 propionyl

0

12 propionyl

0

13 propionyl

0

14 propionyl

0

Sum

37,555,435

yield of full propionylation(%)

86.00

TABLE 4.1. AMIDE-HILIC LC-MS

PEAK AREA OF EXTRACTED ION CHROMATOGRAMS

(EICS)

DATA FOR

PROPIONYLATED ARIXTRA.

Complete propionylation without sulfate loss should result in the addition of six propionyl groups. No
depolymerization products were detected in the HILIC-MS chromatogram. With optimized conditions, the estimated
yield was 86%.
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As the first step of chemical derivatization, one concern was loss of the labile sulfate groups
during the reaction followed by acylation at the site of sulfate loss, giving possibilities of false
identification. In the current protocol, the amount of propionic anhydride, DMAP and TEA were
all over a 1000-fold excess comparing to that of TEA-Arixtra salts. We assumed that if there were
any degree of desulfation, the desulfation site would likely be further propionylated. Based on this
assumption, a broad MS search was performed on the fully propionylated LC-MS ion
chromatogram to identify sulfate loss during propionylation. As shown in Table 4.1, there was
only one desulfation product, losing one sulfate group with one more propionyl group. The ratio
of the desulfation product was 3.7%. Compared to the yield of full propionylation (86%), the
amount of desulfation was low and acceptable.
LC-MS2 and MS3 analysis of derivatized Arixtra
Compared to N-sulfation and 6-O-sulfation on GlcNAc, it is very rare to have 3-O-sulfated
glucosamine naturally, occurring about 1/20 disaccharides in Hp and less than 1/100 disaccharides
in HS 78. Interestingly, 3-O-sulfation is essential for many Hp/HS-protein interactions, including
antithrombin III 483, Herpes simplex virus-1 484, cyclophilin B 485 and fibroblast growth factor 7 486.
Even though it is a rare modification, 3-O-sulfation is vital to diverse biological functions. A good
structural sequencing technique needs to resolve the sulfation pattern, including the site of
sulfation on each glucosamine (N-, or 6-O, and/or 3-O-sulfation). Unfortunately, there are few
commercially available 3-O-sulfated Hp/HS standards. Arixtra is a synthetic, ultralow-molecularweight Hp-based pentasaccharide that potentiates the innate neutralization of Factor Xa by
antithrombin III (ATIII) and interrupts the blood coagulation cascade 487. Arixtra has N-, and 6-O,
and 3-O-sulfation sites in high sulfate density with variability among the GlcN residues, and is a
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challenging model to study the derivatization properties and validate the structural sequencing
method.

FIGURE 4.4. SULFATION SEQUENCING ANALYSIS OF ARIXTRA BY ACYLATION/DESULFATION AND MS/MS.
a. The structure and fragmentation path for derivatized Arixtra; b. Tandem MS spectrum of [M+2H]2+=602.735,
corresponding to fully derivatized Arixtra. -P represents loss of a propionyl group (56.026 Da) and -OMe represents
loss of methanol (32.026 Da) from the reducing end. The mass accuracy for each assigned product ion was below 10
ppm.
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At the MS2 level, oligosaccharides are mainly fragmented via glycosidic bond cleavage.
Based on the glycosidic bond cleavage pattern of acylated and desulfated Arixtra, the number of
sulfate groups on each saccharide was resolved. Fragmentation nomenclature is followed as
described by Domon and Costello 213. As illustrated in Figure 4.4, the mass differences between
the product ion [Y2+H]+ and [Y1+H]+, and [B3+H]+ and [B4+H]+ both demonstrated that there
was one propionyl group and one hydroxyl group, indicating one sulfate group on the GlcA close
to the reducing end. Since only the 2-O position can be sulfated, we located the sulfate position on
the reducing end uronic acid; the same strategy can be used to locate sulfation on any uronic acid.
Similarly, the mass difference between the product ion [Y 3+H]+ and [Y2+H]+ demonstrated that
there was no acylation on the middle GlcN, indicating that this GlcN was initially (NS, 3S, 6S)
trisulfated. With the MS2 spectrum, we could resolve all uronic acid sulfations and the trisulfated
GlcN by glycosidic bond cleavage. While Arixtra does not contain any GlcNAc residues, we
would similarly be able to resolve any GlcNAc-containing residue using the same strategy
(unsulfated or 6S).
The [B1+H]+ product ion indicated that the GlcN on the non-reducing end was
dipropionylated (and, therefore, originally disulfated). Similarly, the [Y 1+H]+ ion indicates that the
GlcN on the non-reducing end was monopropionylated (and, therefore, originally disulfated).
However, localization of sulfates in disulfated GlcN residues is more complex. The addition of 3O-sulfation is one of the last modifications in biosynthesis, and has only been found from
mammalian sources on GlcNS 72, 73, 488. Due to biosynthetic constraints, disulfated GlcN has two
possible structures: the common (NS, 6S) and the rare (NS, 3S). In order to resolve the sulfation
positions on disulfated GlcN, we performed MS3 to generate cross-ring cleavage products. As
illustrated in Figure 4.5, the MS3 of [B3+H]+ gave three major product ions: [1,4X4+H]+,
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[B3Y4+H]+, and [1,4X4 –H2O+H]+. The unique ion, [1,4X4+H]+, indicates that there was a 6-O
hydroxyl group on this GlcN. With these results, we located one sulfate group to the 6-O on the
GlcN of the non-reducing end, placing the other sulfate group on the N-position on the GlcN of
the non-reducing end.

FIGURE 4.5. SULFATION SEQUENCING ANALYSIS OF THE NON-REDUCING END OF DERIVATIZED ARIXTRA BY MS3.
a. Fragmentation path of B3 ion, [B3+H] +; b. MS3 spectrum of [B3+H] + of fully acylated, desulfated Arixtra. The
mass accuracy for each assigned product ion was below 5 ppm.
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Similarly, the annotation of the GlcN on the reducing end followed the same process. As
illustrated in Figure 4.6, the MS3 of [Y1-OMe+H] + gave two major product ions [1,4A5+H] +, and
[Z1-OMe+H] +. The product ion, [1,4A5+H] +, shows that there is one propionylation, indicating
an (NS, 6S) structure for the reducing end GlcN. All assignments are consistent with the known
Arixtra structure, and no other possible assignments are supported by the data. While no
monosulfated GlcN is present in Arixtra, it would be assigned in a similar fashion, using MS 3 to
differentiate between the common GlcNS and the rare GlcN6S.

FIGURE 4.6. SULFATION SEQUENCING ANALYSIS OF THE REDUCING END OF DERIVATIZED ARIXTRA BY MS3.
a. fragmentation path of Y1-OMe ion, [Y1-OMe +H] +; b. MS3 of [Y1-OMe + H] +. The mass accuracy for each
assigned product ion was below 5 ppm.

LC-MS and LC-MS/MS analysis of Hp hexasaccharide mixture
To evaluate and apply our method for structural analysis of native Hp oligosaccharide
mixtures, a Hp hexasaccharide mixture was collected from SEC separation as described above.
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Prior to chemical derivatization and LC-MS/MS analysis, the compositional information of dp6
was collected by HILIC LC-MS. Based on the compositional information, a theoretical mass list
for the corresponding derivatization products of selected detected dp6 compositions were listed in
Table 4.2.
Propionylation
Composition

Mass

sites

Mass after derivatization

[M+2H]2+

DP6 +7S

1571.0004

9

1515.5386

758.7771

DP6+ 8S

1650.9572

8

1459.5124

730.7640

DP6 +6S

1491.0436

10

1571.5648

786.7902

DP6 + 7S +Ac

1613.0110

8

1501.5230

751.7693

DP6 + 6S +Ac

1533.0541

9

1557.5492

779.7824

DP6 + 5S +Ac

1453.0973

10

1613.5754

807.7955

DP6 +5S

1411.0868

11

1627.5910

814.8033

DP6 + 4S +Ac

1373.1405

11

1669.6016

835.8086

DP6+ 9S

1730.9140

7

1403.4862

702.7509

DP6+ 10S

1810.8708

6

1347.4600

674.7378

DP6+ 11S

1890.8276

5

1291.4338

646.7247

DP6+ 12S

1970.7845

4

1235.4075

618.7116

TABLE 4.2. MAJOR COMPOSITIONAL FORMS OF DP6 WAS ASSIGNED BASED ON THE HILIC LC-MS RUN.
The theoretical mass list was generated for these derivatized compositions, and this list of masses were used for an
inclusion list in data dependent acquisition MS/MS.

103

(a)

(b)

(c)

FIGURE 4.7. SEC-UV CHROMATOGRAMS OF A. UNMODIFIED HP DP6, B. PROPIONYLATED HP DP6, AND C. NEGATIVE
CONTROL.

After propionylation, there was only one propionylated hexasaccharide peak with a similar retention time as the
unmodified hexasaccharide, demonstrating the hexasaccharides were fully propionylated. The high retention time
peak after dp6 derivatization was identical to the negative control indicating reagent signal.
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730.763 → 274.128
Z1 ion of Structure 1

730.763 → 330.1541
Z1 ion of Structure 2

FIGURE 4.8. LC SEPARATION OF THE DERIVATIZED HP DP6 MIXTURE.
a. TIC of the derivatized dp6 mixture; b. EIC corresponding to a fully derivatized octasulfated dp6, doubly protonated
(m/z = 730.763); c. MS/MS pseudo-MRM trace of 730.763 → 274.128, corresponding to the [Z1+H]+ product of a
disulfated reducing end glucosamine as shown in Figure 4.9; d. MS/MS pseudo-MRM trace of 730.763 → 330.1541,
corresponding to the [Z1+H]+ product of a monosulfated reducing end glucosamine as shown in Figure 4.10.

Prior to desulfation, the propionylated dp6 was analyzed by SEC-UV. As shown in Figure
4.7, dp6 was fully propionylated without evidence of depolymerization. After peracylation and
desulfation, LC-MS/MS analysis was performed. As shown in Figure 4.8A, the resulting mixture
of derivatized dp6 was incredibly complex. Figure 4.8B shows that even the number of structures
was large, especially for certain composition. Complete analysis of this mixture by manual
annotation is beyond the scope of this manuscript; we focused on six structures from five
compositions to highlight the utility of our method. The mass spectrometry data have been
deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset
identifier PXD021263 489. We annotated one pair of structural isomers (Figure 4.9 and Figure
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4.10) and four other structures: dp6 with 6 sulfo groups, dp6 with 7 sulfo groups, dp6 with 9 sulfo
groups and dp6 with 7 sulfo groups and 1 acetyl group. Development of automated analysis
software as previously described for our previous permethylation-desulfation-acetylation strategy
will be required to allow for thorough characterization of these complex mixtures with this current
strategy 176, 490.
In order to test if our derivatization method allowed for chromatographic separation and
assignment of structural isomers, we focused on two structures for dp6 with 8 sulfation sites.
Figure 4.8C-D clearly shows that, after derivatization, we can achieve separation of structural
isomers of this dp6. The structures illustrated in the pseudo-MRM traces in Figure 4.8C-D are
assigned based on their MS/MS spectra, as shown in Figure 4.9 and Figure 4.10, respectively.
Structure 1 assigned with 6-O- and N-sulfation on the reducing-end eluted around 22.0 min after
derivatization, while Structure 2 assigned with only N-sulfation on the reducing-end eluted around
15.9 min after derivatization. The observed shift in retention time of almost 6 minutes from the
movement of a single sulfation site from the reducing end to an internal residue makes it clear that
chromatographic separation of even very complex mixtures is possible with this method, while the
replacement of labile sulfo groups results in MS/MS spectra that are much more informative.
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(a)

(b)

FIGURE 4.9. SULFATION SEQUENCING ANALYSIS OF STRUCTURE 1 BY ACYLATION/DESULFATION AND MS/MS.
a. The structure and observed product ions for Structure 1; b. Averaged MS/MS spectrum of [M+2H]2+ = 730.763
obtained between 21.90-22.26 min, corresponding to fully derivatized oligosaccharide illustrated in Structure 1. –PA
represents the loss of propionic acid (74.037 Da). The mass accuracy for each assigned product ion was below 10 ppm.
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(a)

(b)

FIGURE 4.10. SULFATION SEQUENCING ANALYSIS OF STRUCTURE 2 BY ACYLATION/DESULFATION AND MS/MS.
a. The structure and observed product ions for Structure 2; b. Averaged MS/MS spectrum of [M+2H]2+ = 730.763
obtained between 16.04-16.39 min, corresponding to fully derivatized oligosaccharide illustrated in Structure 2. The
mass accuracy for each assigned product ion was below 10 ppm.

Conclusions
In this work, a new chemical derivatization strategy was designed to allow the structural
sequencing of sulfated GAGs by MSn fragmentation. The replacement of permethylation with
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acylation simplified the derivatization strategy from a three-step reaction to two-steps and
generated informative product ions. Even more notably, acylation eliminates the widespread
depolymerization problem previously observed with permethylation. The resulting reaction yield
was significantly increased. Therefore, without huge sample loss and the highest derivatization
yield, the strategy would be more reliable to resolve the essential structures of unknown functional
Hp/HS oligosaccharides.
After chemical derivatization, the sulfated GAGs retain well on a standard C18 column
and elute with a typical reverse phase gradient, which was directly compatible to a common
electrospray interface. The assignments based on product ions primarily generated by glycosidic
bond cleavages reveal the amount of sulfo groups on each ring. The resulting cross-ring cleavage
fragments could resolve the sulfation pattern on one partially sulfated (disulfated or monosulfated)
glucosamine. Combing the low detection limit of nano C18 column (normally nmols to pmols),
the resulting method is capable of sequencing even more complex sulfated oligosaccharides with
trace amount and commonly LC-MS instruments.
While all methods have their own advantages at various aspects, there is still no universal
methodology that can accurately sequence complex sulfated GAGs with various sulfation patterns.
The method we describe here has its own limitations as well. While our experiments on Hp were
able to generate a large amount of structural information on a large number of structures and likely
structural assignments could be inferred based on the likelihood of certain modifications, complete
and unambiguous assignment of all possible structures is not achieved with MS/MS. Unlike
permethylation, MS3 is often necessary in this method to locate the sulfate groups on monosulfated
or disulfated GlcN, such as GlcNS3S VS. GlcNS6S or GlcNS VS. GlcN6S. Some reports of
chemoenzymatically synthesized Hp/HS oligosaccharides indicate that 3-O-sulfation can be
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forced onto GlcN residues under some conditions 491; MS3 analysis may be required to structurally
characterize monosulfated GlcN residues that derive from chemoenzymatic synthesis. The effect
of epimerization of uronic acid on the fragmentation pattern of Hp/HS oligosaccharides derivatized
as presented here is also currently unclear; further studies trying to understand these differences
are currently underway. However, due to the high reaction yield, the lack of depolymerized side
products, and the relative robustness of the chemistry, we anticipate that the method we present
here will be more easily adopted by GAG researchers and more applicable to longer GAG
oligosaccharides, opening up new areas of investigation in GAG structure-function analysis.
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CHAPTER V

MASS SPECTROMETRY-BASED FAST PHOTOCHEMICAL OXIDATION OF
CARBOHYDRATES (FPOC) FOR CARBOHYDRATE-PROTEIN INTERACTION
CHARACTERIZATION
Abstract
Carbohydrates exist in various forms in living organisms, such as glycoproteins,
glycolipids, glycosaminoglycans, and other conjugates, which play important roles in biological
processes. Many of these processes are mediated and/or modulated via carbohydrate-protein
interaction. However, the study of this interaction is very challenging. This is mainly due to the
structural complexity of carbohydrates, the dynamic nature of many carbohydrate conformations,
and often low binding affinity of the interactions. In order to study and characterize the
carbohydrate-protein interaction, we are developing a new approach using mass spectrometrybased fast photochemical oxidation of carbohydrates (FPOC). This method characterizes changes
in solvent accessibility of different regions of an oligosaccharide by measuring changes in the
apparent rate of formation of carbohydrate-hydroxyl radical oxidation products. Trisaccharide
isomers and N, N’, N’’-triacetylchitotriose (NAG3) have no significant change of oxidation in the
non-binding protein solutions while oxidation of NAG3 decrease in two binding protein solutions,
demonstrating the screening capability of FPOC. Comparing the oxidation percentages in two
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protein solutions, there is also a more significant decrease in the reducing end binding protein
solution than that in the non-reducing end binding protein solution. Our data suggests that the free
reducing end is the inherent oxidation site and thus FPOC could differentiate the binding end of
glycan. In all, FPOC could not only screen the binding glycan, but could also footprint the binding
end of glycan.
Introduction
There are many types of carbohydrates on the cell-surface, including N-, O-glycans, GAGs,
lipo-oligosaccharides and glycolipids. These carbohydrates bind with various proteins and mediate
a wide range of biological processes 492. These interactions can be monovalent or multivalent. For
example, the interaction between galectin-1 and carbohydrate is mainly based on a monomeric
glycan recognition domain while most cell surface glycan-protein interactions are recognized by
multivalent interactions

111, 493.

In such cases, both structural diversity and density at the cell

surface influence the binding 110. The structural selectivity affects the direct binding affinity while
the density will impact the avidity Kd, the summary of multivalent interactions 494. Usually, the
binding affinity of monovalent interaction is very weak, around mM to M Kd 495. Therefore,
multivalent interaction is developed by pathogen to enhance binding. The binding between glycan
of ganglioside GM1 and non-toxic B subunit of cholera (Kd = 43 nM) extensively elevates the
avidity (Kd ~40 pM) of cholera toxin, further enhancing binding and cellular uptake of toxin 496.
Both apparent affinity and avidity affinity are key kinetic parameters to study the multivalent
glycan-protein interactions.
There are many approaches to study the glycan-protein interactions having both advantages
and disadvantages. Isothermal titration calorimetry is the golden standard to measure the binding
affinity, which measures the released/absorbed heat upon binding with a high accuracy 497. The
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large amount of sample requirement and low resolution limit the application of isothermal titration
calorimetry 498. Cryo-EM significantly improves the resolution to atomic level. It is hard to direct
visualize large oligosaccharides due to their high degree of freedom. NMR, especially 2D NMR,
is an extensive method to explore glycan-protein interactions, like galectin-glycan interactions 499.
However, both cryo-EM and NMR could only accurately characterize interactions between pure
glycan and protein in order to support the assignment of signal. The structural complexity of glycan
limits their application. Moreover, none of them is a high throughput screening method. SPR and
microarray have been developed to perform high throughput screening. Both of them require low
sample amount and can measure affinities from mM to pM, showing great potential to study
glycan-protein interactions. Both can also work with impure samples, although the resulting data
can be difficult to interpret. In order to study the glycan-protein interactions by SPR or microarray,
glycans are usually immobilized on the sensor chips first. For natural glycans, an extra linker has
been crosslinked to glycans prior to immobilization. The purity of glycan samples and printing
density on chips could impact the screening results, which is challenging to heterogeneous natural
glycans.
MS is now commonly used to study glycan-protein interactions. Electrospray ionization
(ESI) MS directly measures the free and glycan-bound protein ions in solution, which does not
need label or immobilization 500. It screens the interactions based on the catch-and-release-ESIMS assay, where the binding glycan first “catches” the protein and then is “released” by CID and
identified by MS 501. Filter-entrapment enrichment pull-down assay coupled MS analysis has been
used to study GAG-protein interactions in a rapid screening manner including various binding
affinities 502. Overall, MS based characterization approach is very useful. However, current MS-
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based technologies generally cannot probe the specific portions of the glycan involved in the
interaction.
In this work, we explore the use of photochemistry coupled with MS to characterize glycanprotein interactions. This study is focused on the change of solvent accessibility, resulted in
decrease of oxidation during binding to screen out the binding glycan and footprint the glycan
binding end via MS. The FPOC-MS workflow can perform functional screening and
characterization of oligosaccharide in glycan-protein interactions.
Experimental
Materials
N, N’, N’’-triacetylchitotriose (NAG3), isomaltotriose, 1-kestose, raffinose and melezitose
were purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA). Hen egg while lysozyme (14
kDa), horse heart myoglobin (17 kDa) and ubiquitin from bovine erythrocytes (8.57 kDa) were
purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA) as well. Lectin extracted from Griffonia
Simplicifolia (28 kDa) was purchased from Vector Laboratories (Burlingame, CA, USA). Water
was purified by a MilliQ system (Millipore, Bedford, MA, USA). All other regular chemical
reagents used in the chemical derivatization were purchased from Sigma-Aldrich Inc. (St. Louis,
MO, USA).
FPOC labeling
In this study, the glycan mixture consisted of five equal amounts of trisaccharides, NAG3,
isomaltotriose, 1-kestose, raffinose and melezitose. Four model proteins in this study were
ubiquitin, lysozyme, lectin, and myoglobin. 50 uM of each protein in 10 mM sodium phosphate
buffer along with 17 mM glutamine as scavenger and 1 mM adenine as radical dosimeter were
mixed with 25 uM of glycan mixture for FPOC. After 1h incubation, FPOC labeling of each protein
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was performed at 150 mM hydrogen peroxide by a 248 nm COMPexPro 102 high pulse energy
excimer laser (Coherent) 503. For control sample, everything was prepared as follows, except the
laser was not turned on. The FPOC labeled products were collected in quench solution, containing
0.5 g/mL catalase and 0.5 g/mL methionine amide, to eliminate excess hydrogen peroxide and
any long-lived secondary oxidants. Proteolytic digestion of oxidized protein was performed by
addition of DTT to final concentration of 5 mM at 95 C. After cooling down to room temperature,
samples were digested overnight with sequencing grade trypsin (Promega) at 37 C with an
enzyme/protein ration of 1:100 (wt/wt). The digested samples were dried until LC-MS/MS
analysis.
LC-MS analysis of FPOC samples
The FPOC samples were analyzed by LC-MS on a Thermo Orbitrap Fusion Tribrid
(Thermo Fisher Scientific) coupled with a Dionex UltiMate 3000 liquid chromatography (Thermo
Fisher Scientific). Buffer A was 10 mM ammonium formate (pH 4.4, adjusted with formic acid)
and buffer B was 98% acetonitrile with 2% buffer A. Online HPLC was performed on a BEH
Amide HILIC column (50 mm × 1 mm, 1.7 µm, ACQUITY UPLC ® BEH Amide, Waters). The
flow rate was set to 0.1 mL/min and a 10 µL injection at a sample concentration of 0.2 µg/ µL.
The gradient started with 90% B for 5 min, with a linear gradient down to 30% B over 60 min,
held at 30% B for 4 min and finally washed with 10% B for 10 min and re-equilibrated with 90%
B for 10 min. The samples were analyzed in positive ion mode with voltage set to 3000 V. Full
MS scan range was set to 150-800 m/z at a resolution of 60000. RF lens was 6% and the automatic
gain control (AGC) target was set to 1.0 × 105.
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Results and Discussion
The purpose of the FPOC strategy is to screen out the binding carbohydrate in a mixture,
comparing the oxidation change based on the solvent accessibility change during binding Figure
5.1. The non-binding carbohydrates and protein will have the full solvent accessibility, suggesting
a consistent oxidation ratio shown in Figure 5.2a. The binding carbohydrate will fit in the protein
binding pocket, resulting in less solvent accessibility and less oxidation shown in Figure 5.2b.
After online HILIC LC-MS analysis, the oxidation percentages of glycans are calculated based on
the peak area. By comparing the oxidation percentage of each glycan in various protein solutions,
we will be able to figure out the binding carbohydrate.

FIGURE 5.1. THE WORKFLOW OF FPOC.
The glycan mixture is mixed with protein, hydrogen peroxide, glutamine, and adenine. The solution then flows through
capillary tube. KrF laser excites hydrogen peroxide in s to ms to hydroxyl radicals, which oxidize the protein and

116

glycans. The reaction is quenched by adding in catalase and methionine amide. After denature and digestion, sample
was then analyzed by HILIC LC-MS.

FIGURE 5.2. THE PROPOSED SCREENING THEORY OF BINDING GLYCAN WITH FPOC.
a. When glycans are in the non-binding protein solution, all glycans have the same solvent accessibility to the fresh
hydroxyl radicals, resulted in similar oxidation percentage. b. While glycan in the binding protein solution, the binding
glycan will be buried in the protein binding pocket, which will have less solvent accessibility and resulted in less
oxidation product compared to that in the non-binding protein solution.

Investigate the oxidation product of glycans.
Based on studies in plants, plant carbohydrates play an important role in reactive oxygen
species scavenging mechanisms 504. The possible reactions between sucralose and hydroxyl radical
(. OH) and singlet oxygen (1O2) has been proposed as following four reactions. (1). The hydroxyl
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radical extracts a hydrogen from either fructose or galactose on sucralose. The sucralose radicals
are then partially hydrolyzed into one monosaccharide without radical and the other
monosaccharide with radical, which will be further oxidized to a keto group (MW - 2). (2) The
sucralose is oxidized first on either monosaccharide unit and followed by hydrogen abstraction,
resulted in MW + 14 products. (3) The sucralose is only oxidized, forming the hydrate product
(MW + 16). (4) The radical products may cause recombination or depolymerization 505. As these
are all possible oxidation products of glycans, a thorough selective mass search of all possible
oxidation products has been performed for each glycan in the chromatogram. Under the current
FPOC condition, our data showed that the oxidized one was the dominant product, MW +16. Thus,
we only studied the amount change of the oxidation product (MW + 16) in the following analysis.
Investigate the oxidation site of glycans.
Hydroxyl radical foot prin ting coupled with MS has been widely applied to
characterize the protein-ligand interaction, which oxidizes the solvent accessible
amino acid side chains at a rate based on a combination of the inherent reactivity and
accessibility

505 .

When oligosaccharides are oxidized, oxidation may occur to each

monosaccharide. To probe the inherent reactivity of carbohydrates, NAG3 was used,
which consists of three identical monosaccharides with a free reducing end and a nonreducing end. After FPOC experiment, both NAG3 and oxidized NAG3 were reduced
prior to LC-MS/MS analysis to investigate the oxidation site on NAG3. However,
only NAG3 could be reduced as shown in Figure 5.4a. The oxidized NAG3 could not
be reduced even under the full reaction conditi on for NAG3. Our data (Figure 5.3)
suggested that the free reducing end of NAG3 was first oxidized to form a carboxylic
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acid group during FPOC shown in Figure 5.4b, which inhibited the derivatives from
further reduction.
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(a)

(b)

(c)

FIGURE 5.3 TANDEM MS SPECTRUMS OF REDUCED NAG3 AND OXIDIZED NAG3
a. Fragmentation path of reduced NAG3, b. tandem MS spectrum of reduced NAG3 in lysozyme, [M+46.065]+,
acetonitrile adduct, c. tandem MS spectrum of oxidized NAG3 in lysozyme, [M+15.995]+.
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FIGURE 5.4. THE POSSIBLE OXIDATION SITE OF NAG3.
a. In order to probe the oxidation site by LC-MS/MS, both NAG3 and oxidized NAG3 were reduced prior to analysis.
But only NAG3 could be reduced. Oxidized NAG3 could not be reduced. b. As the reducing end of oxidized NAG3
could not be reduced, it suggested that the free reducing end was oxidized during FPOC, which could not be further
reduced.

Screen the binding glycan and footprint the oxidation site of glycan
Based on the previous experiment result, the free reducing was proposed to be
the inherent oxidation site of glycans. We then designed the FPOC experiment based
on the hypothesis shown in Figure 5.5. The results are shown in Figure 5.6 and
Figure 5.7. As shown in Figure 5.6, there is no significant change of oxidation
percentage for four non-binding trisaccharide isomers in different protein solutions.
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There is a significant decrease of oxidation percentage of NAG3 in lysozyme (p <
0.0001) or lectin (p < 0.001) than that in the non-binding protein solutions, myoglobin
and ubiquitin.

FIGURE 5.5. THE PROPOSED FOOTPRINT THEORY OF BINDING GLYCAN WITH FPOC.
a. When glycan is in its non-reducing end binding protein solution, reducing end, the inherent reaction site, will have
more solvent accessibility to the fresh hydroxyl radicals, resulted in a higher oxidation percentage. b. While glycan in
its reducing binding protein solution, the reducing end will be buried in the protein binding pocket, which will have
less solvent accessibility and resulted in less oxidation product compared to that in the non-reducing end binding
protein solution.
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FIGURE 5.6. TOTAL

OXIDATION PERCENTAGE OF NON-BINDING TRISACCHARIDE ISOMERS IN FOUR PROTEIN

SOLUTIONS.

Total oxidation percentage of non-binding trisaccharide isomers (25 uM of isomaltotriose, 1-kestose, raffinose and
melezitose) in four protein solutions, respectively (n = 3), P = 0.82 F (3,8) = 0.31 with one-way ANOVA analysis.

****
****

**

FIGURE 5.7. TOTAL OXIDATION PERCENTAGE OF NAG3 IN FOUR PROTEIN SOLUTIONS
Total oxidation percentage of NAG3 in four protein solutions, respectively (n = 3), P < 0.0001 F (3,8) = 113.4 with
one-way ANOVA analysis, adjusted p with Tukey HSD post hoc, ** p < 0.001, **** p < 0.0001
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(a)

(b)

FIGURE 5.8. THE INTERACTIONS BETWEEN NAG3 AND LYSOZYME/LECTIN.
a. the interaction between NAG3 and lysozyme, Red: hydrogen bond, Green: 1-water bridge, and Blue: 2-water bridge
506

. b. the interactions between NAG3 and Urtica dioica agglutinin isolectin VI (UDA-VI). Sugar residues are labeled

with A, B, C from the non-reducing end 507.

NAG3 mainly binds to protein via intramolecular hydrogen bonds 508. As shown in Figure
5.8a, a significant number of hydrogen bond pairings have been found when NAG3 bind to
lysozyme. Some binding is mediated by more water molecules, such as O6 B-Asp 101 and O6CAsp48. The free reducing end of NAG3 has the most solvent mediating hydrogen bonds due to
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solvent accessibility in the cleft-shaped binding site. The hydrophobic contact between an amino
acid and a glycan is also considered as a key factor during interaction 509. The binding complex
reproduces the hydrophobic contact between Trp62 and the sugar ring. As shown in Figure 5.8b,
NAG3 is sandwiched between two lectins. For NAG3, there is also a significant decrease of
oxidation in lysozyme than that in lectin. It confirmed our hypothesis that the free reducing end
was the inherent oxidation site. When the reducing end was buried in the lysozyme binding pocket,
there would be much less oxidation. Based on this reaction preference, we could footprint the
binding end of glycan with the binding protein in the glycan mixture. Even though glycan
microarray and surface plasmon resonance could perform high-throughput functional screening
and help us figure out the binding glycan with the interesting protein, neither of them could
footprint the binding end of glycan with the screening protein. Moreover, the FPOC method could
screen the binding glycan from the mixture, which could be directly applicable to screen natural
glycans without any separations. In the next step, we will apply FPOC method to more complex
glycan mixture, such as released N-glycans or human milk oligosaccharides.
Conclusions
In this work, a novel characterization approach has been designed to study the glycanprotein interaction. Based on the decrease of solvent accessibility during interaction, FPOC-MS
method could screen out the binding glycan from the mixture with the significant lower oxidation.
Also, the free reducing end of glycan is noted as the preferred oxidation site during FPOC. FPOC
could footprint the binding end of glycan during the protein-glycan interaction. Thus, FPOC is a
valuable approach to characterize glycan-protein interactions.
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CHAPTER VI

CONCLUSION
To summarize, the work presents an in-depth approach for functional oligosaccharide
analysis, including the functional study of Hp, enoxaparin and their derivatives on COVID-19
infection, a three-dimensional fractionation of Hp/HS, the chemical derivatization coupled with
tandem mass spectrometry sequencing analysis and a fast-photochemical oxidation of
carbohydrate method.
HS is almost ubiquitously found on the extracellular membrane, which plays an essential
role during viral attachment in COVID-19 infection. Hp, sharing the similar structural properties
with HS, is also able to bind to COVID-19 and thus inhibits the viral attachment. As the interaction
is mainly driven by the electrostatic force, the effects of various sulfation patterns on COVID-19
infection have been studied. Hp and enoxaparin sodium are first selectively desulfated at N- or 6O- position, respectively. The selective desulfation derivatives are then confirmed by NMR prior
to inhibitor screening. Both Hp and enoxaparin sodium show inhibitory effects on viral attachment.
The inhibitory effect is decreased with N-desulfated and full desulfated derivatives while there is
no significant change on inhibitory effect with 6-O-desulfated derivatives. Our data suggests that
N-sulfation is required for viral attachment and Hp inhibits COVID-19 infection, which can be
designed for prophylactic as well as therapeutic approaches.
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Even though Hp inhibits COVID-19 infection, the study of the structure-function
relationship is very challenging. This is because the structural complexity of Hp/HS is multidimensional. With the increasing chain length, there are more variable positions that can be
sulfated, resulted in various sulfate amounts and isomers. In order to carefully study the structurefunction relationship, a three-dimensional fractionation method has been designed, started from
SEC, followed by IPRP, and ended with Amide HILIC. With this fractionation method, the
sulfation isomers (synthetic dp6s) can be fully resolved. The high resolution is further
demonstrated by over seven min of separation on isomers of Hp dp8. Without any purification
steps, fractions from the three-dimensional separation can be directly analyzed by LC-MS and
functional screening by microarray.
In order to sequence sulfated GAGs by tandem mass spectrometry, we have designed a
chemical derivatization approach coupled with tandem mass spectrometry to prevent sulfate loss
from collisional induced activation. In this approach, all hydroxyl groups and free amines are first
replaced by propionyl groups. The labile sulfate groups are then fully removed, forming new
hydroxyl groups and/or amine groups. The neutral hydrophobic derivatives are separated by RP,
ionized on positive ion mode and fragmentated by CID. In tandem mass spectrum, the hydroxyl
groups and amine groups represent the original sulfation sites. Moreover, the two-step
derivatization offers a high yield without depolymerization. It cannot only resolve the sulfation
pattern of Arixtra, but also several structures of Hp dp6. This method offers a marked improvement
in reliability and will be more applicable to characterize the structures of larger sulfated
oligosaccharides.
As glycans are involved in diverse biological functions through carbohydrate-protein
interactions, there is a need to study carbohydrate-protein interactions. The novel FPOC method
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can screen out the binding glycan from glycan mixture without separation, which is more
applicable to complex oligosaccharides having diverse isomers, like N-glycans, sulfated GAGs.
Moreover, FPOC screens binding in solution, which includes all binding possibilities. As the free
reducing end is the inherent oxidation site, FPOC can also footprint the binding end of glycan
during the interaction. Continued work on study of structure-function relationship of functional
oligosaccharide is of great importance to understand their roles in the pathophysiology of major
diseases.
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University of Mississippi

Oxford MS

Ph.D. candidate in Pharmaceutical Sciences (Pharmacology).

2016-2021

Shenyang Pharmaceutical University

Shenyang Liaoning China

M.S. in Traditional Chinese Medicine (Pharmaceutics)
Shenyang Pharmaceutical University

2013-2016
Shenyang Liaoning China

B.S. in Pharmacy (in English)

2008-2013

RESEARCH EXPERIENCE
Industrial Internship
Biogen, Cambridge, MA (01/12/2021-06/18/2021)
Have internship in the Biologics Drug Discovery group
Paratope mapping protein mab interaction with HDX MS
Epitope mapping protein-small molecule interaction with HDX MS
LC-MS/MS proteomics data analysis with PLGS and DynamX
Work with Waters HPLC, Synapt G2-S TOF and LEAP PAL HDX robot.
Involved in method development of antisense oligonucleotide characterization.
University of Mississippi (08/15/2016-07/01/2021)
Graduate Researcher
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•

Be involved in the clinical trial study of using heparin nasal spray to treat COVID19
o Prepare site-specific desulfated heparin and enoxaparin sodium to probe
structure-function relationships of sulfation patterns on SARS-CoV-2
inhibitory activity.
o Prepare near-infrared fluorophore-labeled heparin to test the in vivo
lifetime of heparin in the nasal cavity
Develop a method to study the carbohydrate-protein interaction via fast
photochemical oxidation of protein and carbohydrate (FPOC)
o Use hydroxyl radicals to label solvent-accessible carbohydrates.
o Compare the ratio of oxidation with LC-MS/MS to distinguish the protein
binding carbohydrate and the binding end from the glycan mixture.
o Release N-glycan from ovalbumin with PNGase and study the binding
glycan with the interesting protein.
o Apply this method to study the interaction between the human milk
oligosaccharides and lectin.
Develop a chemical derivatization method coupled with liquid chromatography
and tandem mass spectrometry for structural sequencing of sulfated
glycosaminoglycans
o Propionylate all hydroxyl groups of sulfated GAGs, followed by desulfation
with the highest yield in publications.
o Use nano-LC, tandem MS and MSn spectrum to sequence the initial sulfate
locations either on different rings or on the same glucosamine.
o Present a remarkable improvement in the reliability to structurally sulfated
oligosaccharides sequencing compared to the traditional permethylation
method.
Develop a salt-free multi-dimensional fractionation method compatible with both
mass spectrometry and microarray analysis.
o Separate the complex mixture, heparin, with multiple HPLC separation
methods, such as strong-anion exchange chromatography (SAX), weakanion exchange chromatography (WAX), size exclusion chromatography
(SEC), ion pair reverse phase chromatography (IPRP), and hydrophilic
interaction chromatography (HILIC).
o Develop a three-dimensional HPLC method with a high resolution.
Structural isomers could be separated over 7 min.
o Derivatize the oligosaccharide with fluorescent label and perform
microarray functional screening
o Analyze the fractions with LC-MS on a Thermo Orbitrap Fusion Tribrid.
Develop a method to study the carbohydrate-protein interaction via UV-crosslinker
and tandem MS analysis.
o Label the carbohydrate with a UV-crosslinker through reductive amination.
o Crosslink the carbohydrate with protein by UV radiation.
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o Analyze the digested peptides with LC-MS/MS and find the cross-linked
peptide to probe the binding site.
Shenyang Pharmaceutical University
Master Researcher
o Designed a pH-responsive nanoparticle to promote oral absorption of
oleanolic acid.
o Measured the size of liposome by Zetasizer.
o Performed the X-ray powder diffraction analysis to assess the crystal form
of the lead compound.
o Conducted in situ SPIP study with SD rats and analyzed by Waters HPLC.
o Performed in vivo pharmacokinetic study of the nanoparticle by Waters
UPLCTM system.
o Conducted the morphology study of liposome by transmission electron
microscopy.
o Developed a generic product of Lansoprazole for injection and prepared
application material for CFDA.
o Analyzed the methanol amount in Lansoprazole for injection with GC-MS.
SKILLS
Analytical chemistry: HPLC separation; LC-MS; tandem mass spectrometry; tandem
mass data analysis; GC-MS; Chemical derivatization coupled LC-MS analysis.
Formulation: prepare various formulations, such as nanoparticles, liposome, freezedrying power for injection and tablet; evaluate the formula.

PUBLICATIONS
•
Ritesh Tandon, Joshua S. Sharp, Fuming Zhang, Vitor H. Pomin, Nicole M.
Ashpole, Dipanwita Mitra, MartinG. McCandless, Weihua Jin, Hao Liu, Poonam Sharm
a, Robert J. Linhardt. "Effective Inhibition of SARS-CoV-2 Entry by Heparin and
Enoxaparin Derivatives." Journal of Virology (2021).
•
Hao Liu, Quntao Liang, Joshua S. Sharp. " Peracylation Coupled with Tandem
Mass Spectrometry for Structural Sequencing of Sulfated Glycosaminoglycan Mixtures
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without Depolymerization." Journal of the American Society for Mass Spectrometry
(2020).
•
Hao Liu, Apoorva Joshi, Pradeep Chopra, Lin Liu, Geert-Jan Boons, and Joshua
S. Sharp. "Salt-free fractionation of complex isomeric mixtures of glycosaminoglycan
oligosaccharides compatible with ESI-MS and microarray analysis." Scientific reports
(2019): 1-13.
•
Bezerra, Francisco F., William P. Vignovich, AyoOluwa O. Aderibigbe, Hao Liu,
Joshua S. Sharp, Robert J. Doerksen, and Vitor H. Pomin. "Conformational properties
of L-fucose and the tetrasaccharide building block of the sulfated L-fucan from
Lytechinus variegatus." Journal of structural biology (2019): 107407.
•
Zhang, Wenjuan, Chufan Liang, Hao Liu, Zhenbao Li, Rui Chen, Mei Zhou, Dan
Li, Qing Ye, Cong Luo, and Jin Sun. "Polymeric nanoparticles developed by vitamin Emodified aliphatic polycarbonate polymer to promote oral absorption of oleanolic acid."
asian journal of pharmaceutical sciences (2017): 586-593.
•
Li, Lin, Xingsheng Di, Shenwu Zhang, Qiming Kan, Hao Liu, Tianshu Lu, Yongjun
Wang, Qiang Fu, Jin Sun, and Zhonggui He. "Large amino acid transporter 1 mediated
glutamate modified docetaxel-loaded liposomes for glioma targeting." Colloids and
Surfaces B: Biointerfaces (2016): 260-267.
CERTIFICATIONS
•
Crash Course on Python authorized by Google and offered through Coursera
•
Programming for Everybody (Getting Started with Python) authorized by
University of Michigan and offered through Coursera
•
Python Data Structures authorized by University of Michigan and offered through
Coursera
•
Using Python to Access Web Data authorized by University of Michigan and
offered through Coursera
•
Using Databases with Python authorized by University of Michigan and offered
through Coursera

HONORS
•
2019-Graduate School travel award, University of Mississippi, Oxford, MS
•
2019-ASMS student travel stipend
•
2019-Graduate Student Council Research Grant award, University of Mississippi,
Oxford, MS
•
2019-Graduate Student Council Travel Grant, University of Mississippi, Oxford,
MS
•
2017-Graduate School travel award, University of Mississippi, Oxford, MS
•
2017-ASMS student travel stipend
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